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ABSTRACT
The proximal tubule of the kidney is particularly susceptible to toxicant-induced
damage and cell cultures of human proximal tubule cells are widely utilized to study the
role of epithelial-mesenchymal transition (EMT) in renal disease. Cadmium is a toxic
metal ion that is known to produce renal tubular necrosis and accumulate in the proximal
tubule. This metal binds to a family of cysteine rich metal binding proteins known as
metallothioneins (MT) that are found in abundance in the kidney. Previous studies from
our laboratory have shown that the third isoform of metallothionein (MT-3) is expressed
in the epithelial cells of the human kidney, including those of the proximal tubule. An
immortalized proximal tubule cell line does not express MT-3 and does not demonstrate
vectorial active transport. Transfection of the MT-3 gene into the HK-2 cells restores
vectorial active transport as evidenced by dome formation. This suggests that MT-3 is
involved in mesenchymal to epithelial transition (MET), the reverse of EMT, and
promotes and epithelial phenotype. The goals of the present study were to examine the
role of growth media composition on classic EMT responses, quantitatively evaluate the
expression levels of E- and N-cadherin, define the functional epitope of MT-3 that
mediates MET in HK-2 cells, and identify proteins that interact with MT-3 to promote
epithelial features in the proximal tubule. It was shown that both E- and N-cadherin
mRNA and protein are expressed in the human renal proximal tubule. Based on the
pattern of cadherin expression, vectorial active transport, and transepithelial resistance, it
seems that the HK-2 cell line has already undergone many of the early features associated
xii

with EMT. Our data indicates the unique, six amino acid C-terminal sequence of MT-3
is required to induce MET in HK-2 cells. A combination of co-immunoprecipitation and
western blotting indicate that MT-3 interacts with myosin-IIa, β-actin, enolase-1,
tropomyosin-3, and aldolase-a in vitro. Together, the data suggests the HK-2 cell line can
be an effective model to study later stages in the conversion of the renal epithelial cell to
a mesenchymal cell and when transfected with MT-3 it may be an effective model to
study the process of MET. MT-3 protein-protein interactions provide insight into the
potential mechanism by which MT-3 promotes cytoskeletal organization in non-diseased
epithelial proximal tubule cells and offers the opportunity to investigate these interactions
under pathological conditions.

xiii

CHAPTER I
INTRODUCTION
Significance
The incidence of chronic kidney disease (CKD) is steadily rising and has reached
epidemic proportions in the western and industrialized world. Chronic kidney disease is
associated with albuminuria, decreased creatinine clearance, altered glomerular
morphology, and tubular degeneration (Eddy & Neilson, 2006).

Epidemiological

evidence and animal models have demonstrated chronic cadmium exposure as a
significant contributory factor for developing CKD (Gobe & Crane, 2010; Klaassen,
Liu, & Diwan, 2009; Walter C Prozialeck & Edwards, 2012; Thévenod, 2003)
Clinicopathological studies have shown tubulo-interstitial fibrosis to be the hallmark of
CKD progression (Bohle, Müller, Wehrmann, Mackensen-Haen, & Xiao, 1996; Eddy &
Neilson, 2006; Fine, Ong, & Norman, 1993; Zeisberg & Neilson, 2010). This suggests
that halting the progression of CKD could be achieved by stopping the progression of or
even by inducing remission of fibrosis. Renal fibrosis is defined as the scarring of the
tubulo-interstitial space after kidney damage of any type. It appears to be initiated at
random in small areas that are preceded by interstitial inflammation, then expands to
become diffuse if drivers of fibrosis persist (Prunotto et al., 2012). Accumulation and
proliferation of activated fibroblasts (myofibroblasts) in these small areas are linked to
the risk of progression of fibrosis (Hinz et al., 2007).
1

The exact source

of renal myofibroblasts remains to be definitely defined. Several hypotheses exist in the
literature including: migration of circulating fibrocytes to the site of the lesion,
differentiation of local fibroblasts or pericytes, direct transformation of resident
endothelial cells by endothelial-mesenchymal transition (endoMT), or transformation of
resident epithelial cells through epithelial mesenchymal transition (EMT). Studies in
experimental models have shown that it is the pericytes that respond to chronic injury and
profibrotic signals through proliferation and differentiation into myofibroblasts (S.-L.
Lin, Kisseleva, Brenner, & Duffield, 2008; Picard, Baum, Vogetseder, Kaissling, & Le
Hir, 2008). Fate tracing of pericytes has shown a direct contribution of these cells to
renal fibrosis (Humphreys & Lin, 2010). These studies, taken together, suggest a limited
contribution for a direct conversion of renal epithelial cells, through the process of EMT,
to produce the proliferative pool of fibroblast and myofibroblast cells seen during chronic
kidney injury.
An indirect role for EMT in the progression of CKD can be proposed through
alteration of the tubulo-interstitial microenvironment which can promote fibroblast
proliferation and myofibroblast activation (Prunotto et al., 2012). This microenvironment
would be produced by an alteration in epithelial to mesenchymal cellular cross talk
produced by renal epithelial cells undergoing EMT upon renal injury. A role for an
alteration in the microenvironment by renal cells undergoing EMT is consistent with
early observations which showed that regions of active renal interstitial fibrosis exhibited
a predominant peritubular as opposed to a perivascular distribution (Alpers & Hudkins,
1994; Fine, Norman, & Ong, 1995). In addition, some clinical features of CKD can be
explained by a hypothesis that tubular epithelial cells can relay fibrogenic signals to
2

contiguous fibroblasts in diseased kidneys (Coca, Yusuf, & Shlipak, 2009;
Venkatachalam & Griffin, 2010). However, a role for EMT of renal epithelial cells
producing a pro-fibrotic microenvironment remains a hypothesis supported by general
observations, but not one supported by mechanism.
Hypothesis and Rationale
This study tests the hypothesis that epithelial-mesenchymal transition occurs in
epithelial cells of proximal tubule origin and that cells cultured in the presence of serum
acquire a mesenchymal phenotype.

Further, we hypothesize that the hexapeptide insert

in the C-terminal domain of MT-3 is required for vectorial active ion transport by
interacting with proteins involved in cytoskeletal organization.
One means to study the possible role of EMT in renal epithelial cells and its
relationship to a microenvironment promoting fibrosis is the use of human renal epithelial
cell cultures to model the mechanistic processes underlying the EMT. An examination of
the literature suggests that the HK-2 cell line is the most common human renal epithelial
cell line used to model human renal EMT and related renal disorders. The HK-2 cell line
was isolated by immortalizing and cloning a cell line from a primary culture of proximal
tubule epithelial cells transduced with a construct containing the HPV16 E6/E7 genes
(Ryan, Johnson, & Kirk, 1994). The HK-2 cell line proliferates in a serum-free growth
medium comprised of keratinocyte serum free medium (KSFM) supplemented with
epidermal growth factor and bovine pituitary extract. The HK-2 cell line is available
from the American Type Culture Collection (ATCC) with instructions for growth in a
KSFM medium supplemented with epidermal growth factor and bovine pituitary extract.
The HK-2 cells were shown to have an epithelial morphology and to retain many markers
3

of proximal tubule cells such as alkaline phosphatase, gamma glutamyltranspeptidase,
leucine aminopeptidase, acid phosphatase, cytokeratin, α3β1 integrin and fibronectin.
Functional markers of proximal tubule differentiation also retained were: cAMP
responsiveness to parathyroid hormone, but not antidiuretic hormone; Na+ dependent,
phlorizin sensitive glucose transport; and, the ability to accumulate glycogen.
The present study is designed to address several concerning studies that use the
HK-2 cell line as a model for renal EMT. First, do conditions used for the growth of the
HK-2 cell line influence the results of studies examining the mechanism/s underlying
renal EMT? This question arises since the growth media conditions recommended in the
original publication, and those suggested by the ATCC, have not been employed in many
investigations. A cursory review of the literature discloses that many studies that employ
this cell line to address human renal EMT grow the HK-2 cells in various growth
formulations containing fetal calf serum (Bai, Zeng, Zhou, & Liao, 2012; Berzal, Alique,
& Ruiz-Ortega, 2012; W. Ding, Yang, Zhang, & Gu, 2012; Eneling, Brion, Pinto, &
Pinho, 2012; Guillén‐Gómez, 2012; Q. Li, Liu, Lv, & Ma, 2011; Y. Li et al., 2010; H.
Lin, Wang, Wu, & Dong, 2011; Masola, Gambaro, & Tibaldi, 2012; Veerasamy &
Nguyen, 2009) as opposed to those using the recommended growth medium (Dudas,
Argentieri, & Farrell, 2009; Dudas & Sague, 2011; Grabias & Konstantopoulos, 2012;
Sarközi, Flucher, & Haller, 2012; Yuan, Chen, Zhang, & Huang, 2012). One could
speculate that growth media containing serum would in itself promote EMT and provide
a more profibrotic growth environment than growth medium formulations without serum.
To examine this question, the present study determines the expression of two common
markers of EMT, E-cadherin and N-cadherin, as a function of the growth media
4

composition used for the growth of the HK-2 cells. In addition, previous studies from
this laboratory demonstrated that the HK-2 cell line grown on serum-free growth medium
had lost the ability for vectorial active transport as noted by a lack of dome formation and
transepithelial resistance (Bathula, Garrett, & Zhou, 2008; Kim, Garrett, Sens, Somji, &
Sens, 2002). The present study is also designed to determine if the loss of vectorial
active transport was influenced by the presence or absence of serum in the growth
medium of the HK-2 cells.
A second question explored in the present study, to what degree did the
immortalization process used to isolate the HK-2 cell line advance the process of EMT
compared to the parental cell line? This question is important since it is possible that the
HK-2 cells may have already undergone a significant degree of the EMT. Evidence for
this concept comes mainly from studies by this laboratory which developed the serumfree culture conditions for the growth of mortal cultures of human proximal tubule (HPT)
cells that retain many of the differentiated features of the renal proximal tubule (Detrisac,
Sens, Garvin, Spicer, & Sens, 1984; D. A. Sens et al., 1999; Todd, McMartin, & Sens,
1996).

Similar cultures are now currently available from a number of commercial

suppliers along with kits to support serum-free cell growth (some proprietary). In two
related studies, this laboratory compared several properties of the HPT and HK-2 cells
when grown on identical serum-free growth media (Bathula et al., 2008; Kim et al.,
2002). It was shown that when compared to the HPT cell line, the HK-2 cells had lost the
capacity for vectorial active transport as noted by the inability to form doming structures
(Kim et al., 2002). In agreement with the absence of domes, the HK-2 cells, when
compared to the HPT cells, were also shown to not generate transepithelial resistance and
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to lack the presence of tight junctions (Kim et al., 2002). A corresponding analysis of Eand N-cadherin expression between the cell lines demonstrated a decrease in E-cadherin
and an increase in N-cadherin when the HK-2 cells were compared to the HPT cells
(Bathula et al., 2008). The determination of the E- and N-cadherin protein levels were
qualitative in this past study and a goal of the present study is to quantify the differences
in E- and N-cadherin expression between the cell lines and to determine if additional
differences exist in cell-to-cell junctional communication. The goal is to confirm that
early features of EMT, such as the loss of cell-to-cell junctional integrity and a shift
between E- and N-cadherin have already taken place in the HK-2 model system. The
above studies (Bathula et al., 2008; Kim et al., 2002) also demonstrated that the HK-2
cell line could undergo a reversal of the EMT process (MET) and regain vectorial
epithelial transport, undergo a switch in E-, N, and K-cadherin expression, and regain
junctional integrity upon stable transfection with the gene encoding the 3rd isoform of the
metallothionein protein (MT-3). MT-3 is a multifunctional protein, playing roles in zinc
and copper homeostasis, prevention of oxidative damage, protection against heavy metal
toxicity, ion transport and it may also potentially maintain epithelial cell polarity, a
property postulated to be attributed to the interaction of MT-3 with proteins involved in
cytoskeletal organization. An additional goal of the present study, therefore, is to define
the functional domain of MT-3 eliciting increased MET in HK-2 cells, and confirm
putative MT-3 interacting proteins.
Epithelial Cell Adhesion and Polarity
Polarized epithelial cells are composed of distinct apical, lateral, and basal plasma
membrane domains. Cells of transporting epithelia, including proximal tubule epithelial
6

cells, form specialized junctional complexes that connect lateral domains of adjacent cells
and attach the basolateral domain to the ECM, forming epithelial sheets that line organs.
These complexes are necessary for both the restriction of permeability and the normal
transport of molecules across the cell monolayer, while additionally contributing to the
maintenance of proper cell polarity. The lateral complexes include the zona occludens,
normally referred to as tight or occluding junctions, the adherens junctions, desmosomes,
and gap junctions. Hemidesmosomes are the junctional complex that link the basolateral
membrane to the ECM. Specific cell adhesion and junction associated proteins comprise
these complexes and include the cadherins, catenins, integrins, connexins, among others.
These proteins are associated with actin filaments and cytoskeletal structural elements of
individual cells within the epithelial sheet.
The tight junctions function to seal the cytoplasm of adjacent cells from one
another, and are primarily comprised of the occluden and claudin family of proteins.
These lateral junctions are nearest to the apical surface of epithelial cells, and integrity of
these complexes promotes tight association of adjacent cells while also functioning as a
barrier against solutes entering the extracellular space between cells and interacting with
the lateral domains of adjacent cells.
The adherens junctions are responsible for lateral intercellular anchorage and are
mediated by the calcium dependent cell adhesion protein E-cadherin. E-cadherin is a
single pass transmembrane protein that is the main structural component of this junctional
complex. The intracellular domain is composed of a complex of proteins required for
linking E-cadherin to the actin cytoskeleton, and is made up of alpha-catenin, betacatenin, and alpha actinin. The extracellular domain of E-cadherin is responsible for the
7

adhesive properties of E-cadherin, containing calcium binding sites in addition to the
adhesion domain. Calcium binding to this domain increases the rigidity of the molecule
that correctly orients the adhesive region to participate in homotypic interaction with
neighboring E-cadherin molecules, ultimately serving to connect the actin cytoskeletons
of adjacent cells.
Gap junctions allow for intercellular communication between epithelial cells and
are also located at the lateral domain of the plasma membrane of epithelial cells. They are
formed by the connexins, a family of channel forming proteins that directly connect the
cytoplasms of neighboring cells. These channels allow inorganic ions, glucose, amino
acids, nucleotides, and intracellular mediators to pass through mediating communication
between not only adjacent cells, but throughout the epithelial sheet.
The basolateral domain is oriented away from the lumen of the tubule and
functions to take up metabolic waste into the epithelial cell for transport to the luminal
filtrate, where it can ultimately be excreted in the urine. These specialized basolateral
membranes are also responsible for transporting ions and substrates, including glucose,
from the lumen back to the interstitial fluid.

The apical membrane localizes the polarity

complexes, Par and Crumbs. The apical membrane is composed of a dense covering of
microvilli (also called the brush border) which serve to increase the surface area of this
membrane which in turn aids in absorption capabilities from the luminal filtrate into the
proximal tubule.
Epithelial-Mesenchymal Transition
EMT is a process where epithelial cells lose cell-cell adhesion, apical basolateral
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cell polarity, and gain migratory capabilities ultimately becoming mesenchymal cells.
This process is essential for development and wound healing, and dysregulation of EMT
can be pathogenic resulting in organ fibrosis or the initiation of metastasis in cancer
progression. Mesenchymal-epithelial transition (MET), the reverse process of EMT, also
occurs during development.
There are three types of EMT that occur during development, wound healing (or
fibrosis), and cancer metastasis.

Developmental EMT (Type I) occurs during

gastrulation, neural crest cell migration, and organ development. EMT occurs in order to
generate mesenchymal cells to form secondary epithelia through MET. Wound healing
(Type II) EMT serves to generate fibroblasts following tissue injury. Unfortunately,
failure to regain homeostasis by MET of fibroblasts or to attenuate inflammatory
mediators leads to organ fibrosis. This is particularly problematic for the kidney, liver,
lungs, and intestines as they are more susceptible to fibrotic injury than other tissues.
Cancer metastasis (Type III) is the EMT process in which neoplastic cells gain migratory
capabilities and are able to leave the primary epithelial tumor site by degrading the
extracellular matrix, invading through the basement membrane, intravasating the
endothelium to circulate. These cells will extravasate the blood vessel at a favorable site
and undergo MET to form a secondary tumor in a different organ.
The steps in the progression of EMT are well characterized. Disassembly of
lateral intercellular junctions is one of the earliest steps in EMT, followed by the
dissociation of proteins critical for lateral actin anchorage and epithelial cell polarity.
Changes in gene expression result in the transcriptional induction of pro-mesenchymal
genes and the down-regulation of pro-epithelial gene expression.
9

Finally, actin

reorganization results in the formation of stress fibers attaching the ECM, MMP mediated
ECM degradation, and the acquisition of migratory capabilities.
Dissociation of tight junctions, the lateral junctions in closest proximity to the
apical surface that seal cells from one another, is one of the earliest steps in EMT. This
results in the redistribution of molecules critical for cytoskeletal organization and disrupts
the cell polarity complex.
Next the adherens junctions (and desmosomes), intercellular anchoring junctions,
are disassembled.

E-cadherin is the main structural/scaffolding component of the

adherens junction. Disruption of these specialized cell-cell complexes leads to
redistribution of these mediators in the cell and no longer anchors adjacent cells to one
another. Following the loss of junctional complexes and the down-regulation of Ecadherin, sequestered β-catenin, a key EMT mediator is freed.

Under normal

physiological circumstances β-catenin is phosphorylated by GSK3β, targeting it for
ubiquitination and proteasomal degradation.

During EMT, β-catenin escapes

phosphorylation, accumulates in the cytosol, ultimately enabling the molecule to
translocate the nucleus.

Importantly, this translocation event is the convergence of

several known EMT inducers and may be the most critical step for the induction of full
EMT.
This nuclear translocation event results in β-catenin binding to the TCF/LEF
complex, and the promotion of a mesenchymal phenotype. There is a shift in
transcription of epithelial markers to mesenchymal markers, controlled by Snail 1/2, Zeb
1/2, Twist-1 and multiple bHLH family of transcription factors.
repress E-cadherin and promote N-cadherin expression.
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These function to

Additionally, vimentin, α-

smooth muscle actin, and matrix metalloproteinases (MMPs) are increased. The actin
cytoskeleton is disrupted contributing to the loss apical-basolateral polarity and gain of
front-back polarity. This reorganization promotes migratory capabilities of cells, further
increased MMP production and activation-mediated degradation of the matrix facilitates
migration. Transforming growth factor-beta is a potent EMT inducer that acts by binding
to heteromeric TGFβ receptor type I/II complexes at the plasma membrane, initiating a
signaling cascade involving SMAD 2/3 phosphorylation, colocalization of the phosphoSMAD 2/3 complex with SMAD 4, and nuclear translocation of the complex (Y. Liu,
2009).

Nuclear translocation of the complex activates the expression of several target

genes that promote a mesenchymal phenotype.
General markers of EMT are well defined; however none appear to be unique to
the specific type of EMT. Clinical studies have demonstrated the upregulation of
mesenchymal markers in tubular epithelial cells in several progressive kidney disorders,
including vimentin, α-smooth muscle actin and FSP1.
Cadmium is Nephrotoxic
Cadmium is a toxic metal ion and is considered an environmental pollutant and
has no known physiological function in humans. Cadmium is ranked eighth in the Top
20 Hazardous Substances Priority List (ATSDR, 2012) and is classified as a human
carcinogen (IARC, 1993). Cadmium is a naturally occurring element, and is found in the
Earth’s crust in mineral rich deposits. Naturally occurring events including: soil erosion,
rock abrasion, and volcanic eruptions release cadmium into the environment (ATSDR
2012). Additionally, cadmium dust is released during forest fires.
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Human exposure to cadmium occurs mainly through the gastrointestinal and
respiratory systems. Crops grown in contaminated soil are the largest contributors to
gastrointestinal exposure, and smoking leads to the highest respiratory exposure to
cadmium. Plants that contain the largest concentrations of cadmium include lettuce,
spinach, potatoes, peanuts soybeans, and sunflower seeds (ATSDR 2012). Additional
dietary sources of cadmium exposure include shellfish and the livers or kidneys of
animals that have ingested cadmium (ATSDR 2012, Satarug 2004). Individuals are also
occupationally exposed in industrial settings such as zinc and iron refineries, welding of
cadmium coated steel, formulation of cadmium pigments, and production nickelcadmium batteries or cadmium (NTP, 2011).
Cadmium was first identified in 1817 by Stomeyer as a byproduct of zinc
refining. It was not appreciated to have detrimental health consequences until the late
1950’s when an outbreak of Itai-Itai disease occurred in the region of the Jinzu River
basin, a cadmium-polluted region, in Japan.

Zinc mining in this region released

significant quantities of cadmium into the Jinzu River, killing nearly all the fish. This
river was the irrigation source for nearby rice paddies, and the main source of drinking
water. In 1968 Itai-Itai was officially recognized to be caused by cadmium exposure
when epidemiological evidence demonstrated that cadmium was the only source that
could explain the restricted development of the disease in this area of Japan. The toxicity
is exerted on the kidneys where tubular and glomerular injury results in renal
dysfunction; gout also occurs as a side effect of kidney dysfunction. Additionally, the
bones are damaged due to osteomalacia and osteoporosis.
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Cadmium is toxic to several tissues, and the pathological consequences of
cadmium are dependent upon the dose and duration of exposure (ATSDR 2012, Liu
2007a,b).

Acute cadmium poising primarily targets the liver, with cadmium

hepatotoxicity as the major cause of lethality from an acute exposure (Goering 1983,
Klassen 1999).The main target organ of chronic exposure to cadmium is the kidney.
Cadmium impairs tubular and glomerular function, and accumulates in the proximal
tubule. Cadmium is a cumulative toxin with a recommended daily limit of intake in
humans of 0.3 ug/kg (Choudry 2001). When levels of cadmium accumulation have
reached 150-200 μg cadmium/g tissue in the proximal tubule, dysfunction begins to
occur. Deficiencies in glomerular filtration rate (GFR), and impaired reabsorption of
various solutes including low molecular weight proteins, glucose, amino acids, phosphate
and sodium characterized by proteinuria, glucosuria aminoaciduria, phosphaturia and
hyperosmolar polyuria are reliable indications of proximal tubule damage The long
biological half-life of cadmium, ranging from 15-30 years (ATSDR 2012), is most likely
due to the fact that cadmium is non-biodegradable and relatively redox inert. Information
on the biotransformation of cadmium is limited, with literature support for cadmium
conjugation to sulfhydryl groups of proteins including MT and glutathione. Most of the
cadmium that is absorbed will ultimately be stored in the kidney, and to a lesser extent in
the liver for several years with only a small percentage eliminated through excretion in
the urine and bile respectively.
While the toxic effects of cadmium are well characterized, the molecular
mechanisms of toxicity remain to be fully characterized. Several investigations designed
to elucidate its cytoxic effects have revealed cadmium to alter a variety of cellular
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functions including alteration in the activity of several enzymes, interference with
essential metal ion activities, induction of oxidative stress and apoptosis, inhibition of
mitochondrial ATP production, and alterations in gene expression.
As cadmium is a nonessential ion, there are no known ion transporters specific for
cadmium. Multivalent cations have relatively small atomic radii, so toxic metal ions such
as cadmium appear to gain entry through molecular mimicry of calcium, zinc, iron and
magnesium. Cadmium uses molecular mimicry not only to gain entry to the cell, but also
to exit the lysosome to return to the cytosol and to enter the mitochondria (Bridges &
Zalups, 2005).

Cadmium is absorbed from the gastrointestinal tract after ingestion by

binding to the divalent metal ion transporter-1 (DMT1 or SLC11A2) in the duodenum.
As the name suggests, this transporter carries several other metal ions including iron and
zinc (Mn > Cd > Fe > Pb > Zn). Individuals deficient in essential metals such as iron are
susceptible to increased cadmium transport into cells due to increased expression of
divalent metal ion transporter 1 (Vesey, 2010). Once in the plasma, cadmium binds to
albumin and is transported into the liver.

Within the liver, cadmium induces

metallothioneins, to which it binds with high affinity (Sabolić, Breljak, Skarica, & HerakKramberger, 2010). Cadmium binding to glutathione allows for excretion through the
bile, while cadmium-metallothionein complexes are transported back into the plasma
following necrosis or natural turnover of hepatic cells. Free filtration of these complexes
in the glomerulus allows for the subsequent reabsorption of the cadmium-metallothionein
complex from the lumen of the proximal tubule at the apical face of the epithelium
(Tang, Sadovic, & Shaikh, 1998). This occurs by endocytosis mediated by the megalin
receptor. Once in the proximal tubule, stable cadmium –metallothionein complexes are
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degraded by the lysosome (Vesey, 2010).

Due to the acidic environment of the

lysosome, cadmium is displaced from metallothionein, and gains entry back into the
cytosol to exert detrimental effects or be sequestered by metallothioneins. Additionally,
divalent metal ion transporter 1 is also present on proximal tubule cells, and may be the
transporter responsible for free cadmium export from endosomes and lysosomes that
have internalized cadmium-metallothionein complexes. Cadmium is also capable of
entering the mitochondria where it targets complex III of the electron transport chain
impairing ATP generation, lowering the energy status and capabilities of the cell (Gobe
& Crane, 2010). The proximal tubule is mitochondria rich in order to maintain the high
ATP required for transport.

This results in lower capabilities to “rescue” useful

substances from the lumen of the proximal tubule. If cadmium concentrations remain
high, the mitochondrial disruption generates increasing levels of reactive oxygen species
(ROS) with release of cytochrome c, inducing the caspase cascade and subsequent
apoptosis. In addition to divalent metal ion transporter 1 and megalin, ZIP8 (SLC39A8),
and ZIP14 (SLC39A14) have been identified as transporters capable of allowing
cadmium entry into the cell.
Cadmium has also been demonstrated to disrupt adherens junctions in the
proximal tubule (W C Prozialeck, 2000; W. Prozialeck, Lamar, & Appelt, 2004; Walter
C Prozialeck, Lamar, & Lynch, 2003) by selectively disrupting E-cadherin-dependent
intercellular junctions by interfering with calcium binding. Cadmium also disrupts tight
junctions by altering the distribution of claudins 2 and 5 (Walter C Prozialeck et al.,
2003).
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Metallothioneins
The metallothioneins (MT) are a family of cysteine-rich metal binding antioxidant
proteins consisting of four functional protein isoforms, MT-1, MT-2, MT-3, and MT-4.
These proteins range from 61 to 68 amino acids with highly conserved primary and
secondary structure. The investigation and discovery of metallothioneins was initially
closely associated with the search for tissues containing cadmium by Valee and
Margoshes (Vallee, 1979). The first study to report the presence of cadmium in the
human kidney was initially published by Maliuga in 1941, however this report was not
available to western scientists until the mid-1950s. This finding led to the identification
of cadmium in the kidneys of other mammalian species, and the initial identification of a
protein containing cadmium, as well as substantial levels of zinc and iron, fractionated
and purified from the kidney cortex of a horse. Chromatographic separation revealed the
presence of the two isoforms, MT-1 and MT-2 (19), with a low molecular weight of 6-7
kDa, high sulfur and metal content. Further protein sequencing revealed that of the 61
amino acids composing the single polypeptide chain, 20 residues were cysteines with
distinct clustering into Cys-X-Cys, Cys-Cys, and Cys-X-X-Cys (Piscator, 1964).
Subsequent toxicological studies involving cadmium administration to small animal
models identified increased amounts of MT in the liver. This led to the initial hypothesis
that biosynthesis of MT is induced by cadmium for metal detoxification (Piscator, 1964).
Later studies found dietary administration of copper and zinc also capable of MT
induction in the liver and kidneys of small animal models (Nordberg & Kojima, 1979).
Several studies by Valee and others determined the kidney to be the primary site of
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cadmium accumulation and toxicity in chronic exposure models, typically in a complex
with metallothionein.
Due to the observation that cadmium-metallothionein complexes accumulate in
the proximal tubule and exert toxicity in chronic exposure models, it was a long held
paradigm that metallothionein was detrimental in the context of cadmium exposed animal
models.

This paradigm shifted when mice administered cadmium-metallothionein

complexes displayed less toxicity than those administered cadmium alone. Further,
metallothionein null mice (incapable of producing metallothionein) chronically exposed
to cadmium display enhanced sensitivity to cadmium induced nephropathy (J. Liu, Liu,
Habeebu, & Klaassen, 1998). It is now generally accepted that metallothioneins are
protective against cadmium toxicity.
Metallothioneins readily bind metal cations, and under normal physiological
conditions bind preferentially to copper and zinc. There are two distinct metal binding
domains in each isoform, the β-domain near the N-terminal region, and the α-domain
near the C-terminal region (Vašák & Meloni, 2011). Typically the β-domain binds threedivalent cations, while the α-domain binds four-divalent cations, forming two distinct
metal thiolate clusters. Metal bound MTs are more stable than apo-MT (metal free) and
are less susceptible to lysosomal degradation. In fact, molecular mechanic-molecular
dynamic calculations of apo-MT indicate no structural stability and is predicted to form a
random coil conformation (Rigby Duncan & Stillman, 2006). Using a combination of
circular dichroism and NMR to evaluate the metal composition of metallothionein,
determined that the preferential state contains

seven divalent metal ions

per one

metallothionein molecule (Meloni, Polanski, Braun, & Vasák, 2009), with metal status
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ranges from 5-10 divalent metal ions per molecule of metallothionein (Sutherland &
Stillman, 2011).
MT-1and MT-2 are ubiquitously expressed at high levels. These isoforms are
readily inducible in response to perturbations in cellular homeostasis and are particularly
responsive to metal induction in animal models following dietary administration of
cadmium copper or zinc. The promoter regions of these genes contain metal response
elements (MRE) that induce gene expression when cellular levels of essential or toxic
metals are increased. These isoforms are also responsive to hypoxia, oxidative stress,
steroids, and hormones. MT-3 and MT-4 exhibit more restricted tissue specific
expression, with the highest distributions classically recognized to localized to the CNS
and stratified epithelium respectively.
Metallothionein isoform 3
For more than a decade this laboratory has rigorously investigated tissue
distribution of MT-3 and the role this isoform may play in cellular homeostasis and
disease(S H Garrett, Somji, Todd, & Sens, 1998; Scott H Garrett et al., 2002; S Somji,
Garrett, Sens, & Sens, 2006; Seema Somji et al., 2011; Todd et al., 1996). MT-3 was
first identified by Uchida and colleagues in 1991 in cortical neurons and to a lesser extent
in a distinct population of astrocytes in the gray matter. MT-3 inhibited survival and
neurite formation of cortical neurons in vitro, and was found to be down regulated in
astrocytes from brains affected by Alzheimer’s Disease (Uchida, Takio, Titani, Ihara, &
Tomonaga, 1991). MT-3 exhibits tissue-specific expression differentiating this isoform
from the ubiquitously expressed MT-1 and -2. The distribution of MT-3 is not restricted
to central nervous system as the classical view suggests; components of normal skin and
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kidney express MT-3 (Scott H. Garrett, Sens, Todd, Somji, & Sens, 1999; Slusser et al.,
2014). Additionally, MT-3 is expressed in several types of cancer including breast,
bladder, prostate, and skin (Satarug, Garrett, Sens, & Sens, 2010; M. A. Sens et al., 2000;
Zhou et al., 2006).
The first unique function, growth inhibitory activity, can be attributed to the βdomain of MT-3, with one study attributing this activity to the proline insert (Sewell,
Jensen, & Erickson, 1995) and another to E23 (Z. Ding, Teng, Cai, & Wang, 2006). MT3 also influences the mechanism of cell death a stressed cell undergoes (apoptosis or
necrosis) and that the β-domain influences this activity (Seema Somji, Garrett, Sens,
Gurel, & Sens, 2004; Seema Somji, Garrett, Sens, & Sens, 2006).

MT-3 can also

participate in thiol-disulfide exchange reactions with other cysteine-containing proteins
when the β-domain is bound to four-copper ions leaving two cysteine residues free to
participate in thiol/disulfide exchange (Ghazi, Martin, & Armitage, 2010; Meloni, Faller,
& Vasák, 2007).
The deviations in the primary sequence of MT-3 from the other isoforms are
thought to be responsible for unique functions of MT-3. There is an additional threonine
in the N-terminal domain, an alanine to proline substitution in the β-domain, and a six
amino acid insert in the C-terminal domain. This proline induces a kink in the structure
of MT-3 and the six amino acid insert consists of acidic amino acids. These differences
manifest structurally and influence the interactions of MT-3 with other proteins.
Metallothionein-3 Protein-Protein Interactions
The existing literature describing protein interactions with MT-3 have been
limited to investigations within the CNS (Durand, Meloni, Talmard, Vašák, & Faller,
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2010; Meloni & Vašák, 2009). This is not entirely surprising due to the classical view
that tissue distribution of MT-3 is restricted to neurons and astrocytes. However, in 1999
Garret and Sens demonstrated that MT-3 is expressed in several epithelial components of
the nephron using immunohistochemistry. The highest levels of MT-3 were observed in
several components of the renal cortex; moderate staining was observed in components of
the glomerulus, including parietal epithelial cells of Bowman’s capsule and visceral
epithelial cells of the glomerular tuft, moderate staining was observed in epithelial cells
of the proximal tubule, and strong cytoplasmic staining in the distal tubule. MT-3
staining was more variable in components of the medulla; staining was weak to moderate
in the medullary collecting ducts and absent in the ascending and descending loops of
Henle, and transitional epithelium of the renal pelvis (Scott H. Garrett et al., 1999)
The context for studying proteins interacting with MT-3 in the CNS arises from
the observation by Uchida in the late 1980s that extracts from Alzheimer’s Disease
affected brains enhanced the survival of cerebral cortical neurons when compared to
normal brain extracts (Uchida 1988). Subsequent comparative analysis of the diseased
brain extracts to normal brain extracts attributed this feature to a protein they termed
growth inhibitory factor (GIF); it was hypothesized that GIF was involved in the
formation of senile plaques and enhanced sprouting (Uchida 1989). However, follow-up
studies indicated a correlation to reduced GIF activity and the presence of neurofibrillary
tangles, not senile plagues (Uchida 1991). Additionally, GIF was identified to be a
metallothionein, the third isoform identified.

Since this initial characterization, several

laboratories studying AD have sought to characterize the mechanism by which MT-3
contributes to the pathogenesis of AD by investigating protein-protein interactions and
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MT-3-mediated metal swap events.

Several protein-protein interactions have been

identified (Table 1).
The fact that protein interactions with MT-3 are studied in the context of AD
where the pathological state is characterized by neurofibrillary tangles (Tau tangles) and
senile plagues (Aβ plagues) may provide some insight for studying interacting proteins
with MT-3 in the context of CKD. When viewed in simplistic terms, tangles and plagues
are an accumulation of dysregulated protein aggregates that contribute to the pathology of
AD; the accumulation of dysregulated protein aggregates is a pathological hallmark of
fibrosis observed in CKD.

Interacting
Protein
Transthyretin
Rab3A GTPase
Hsp90
Hsp70
Drp2
Creatine Kinase
B-actin
Exo84
14-3-3
Enolase-1
Aldolase 1 and 3
Pyruvate Kinase
Malate
Dehydrogenase
Tubulin α3
Gelsolin
Myosin-9
B-actin
Tropomyosin 3

Table I-1. MT-3 interacting proteins
Generalized
Reference
Function
Thyroxine Transport
Martinho et.al 2010
Exocytosis
Kang, Chen, Ren, & Ru, 2001
Secretion/Stress
Lahti et al. 2005
Secretion/Stress
Lahti et al. 2005
Neuronal growth
Lahti et al. 2005
Glycolysis
Lahti et al. 2005
Structure/Scaffolding
Lahti et al. 2005
Exocytosis
Ghazi, Martin, & Armitage, 2011
Protein signaling
Ghazi, Martin, & Armitage, 2011
Glycolysis
Ghazi, Martin, & Armitage, 2011
Glycolysis
Ghazi, Martin, & Armitage, 2011
Glycolysis
Ghazi, Martin, & Armitage, 2011
Glycolysis
Ghazi, Martin, & Armitage, 2011
Scaffolding
Ghazi, Martin, & Armitage, 2011
Structure/Filament
Bathula, 2010
Cytoskeleton
Bathula, 2010
Structure/Scaffolding
Bathula, 2010
Cytoskeleton
Bathula, 2010
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Tissue
CNS
CNS
CNS
CNS
CNS
CNS
CNS
CNS
CNS
CNS
CNS
CNS
CNS
CNS
Kidney
Kidney
Kidney
Kidney

CHAPTER II
METHODS
Immunohistochemistry
Tissue sections for the immunohistochemical analysis of E- and N-cadherin
expression in human kidney were obtained from archival paraffin blocks of previously
completed patient diagnostic procedures. These archival specimens contained no patient
identifiers and use was approved by the University of North Dakota Internal Review
Board. Three cases from renal cell carcinomas were utilized in the present analysis and
areas of normal kidney were selected for use by a diagnostic pathologist. These archival
specimens were routinely fixed in 10% neutral-buffered formalin for 16-18 h and were
transferred to 70% ethanol and subsequently dehydrated in 100% ethanol.

The

dehydrated tissues were cleared in xylene, infiltrated, and embedded in paraffin. Serial
sections of formalin fixed and paraffin embedded tissues were cut at 5 μm, deparaffinized
in xylene and rehydrated in graded ethanol and water. Prior to immunostaining, antigen
retrieval was performed by immersing the sections in Dako Target Retrieval Solution
(Code S1699) and heated in a steamer for 20 minutes. The sections were allowed to cool
at room temperature for 30 minutes and immersed in TBST (Tris-buffered saline with
0.1% Tween 20) for 10 minutes. The E and N-cadherin were detected by incubating the
sections with anti-E cadherin (Santa Cruz; 1:100) and anti-N cadherin (Zymed; 1:100) for
30 minutes at room temperature. The identities of the tubular elements chosen for
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subsequent microdissection were identified by the differential immunostaining sections
for aquaporin-1 and calbindin (Bedford, Leader, & Walker, 2003; Kirk, Campbell, &
Bass, 2010; Kiuchi-Saishin & Gotoh, 2002). Aquaporin-1 and calbindin were detected
by incubating sections with anti-aquaporin (Ab9566, Abcam, Cambridge, MA, 1:400)
and anti-calbindin (McAb 300, Swant, Switzerland, 1-800) for 30 minutes at room
temperature. The sections were then incubated with Dako Envision+ Dual Link System
(Code K4061) for 30 minutes at room temperature. Liquid diaminobenzidine (DAB) was
used for visualization. After counterstaining with hematoxylin, the slides were rinsed in
distilled water, dehydrated in graded ethanol, cleared in xylene, and coverslipped.
Laser-Capture Microdissection
The parafin-embedded specimens were also used to determine the expression of
E- and N-cadherin mRNA in proximal tubule cells of human kidney. Five μm thick
sections were cut and mounted onto sterile plain glass slides. The slides were heated at
60°C for 25 min followed by incubation in xylene solution for 5 min and transferred into
fresh xylene solution for an additional 5 min to deparaffinize the sections. The slides
were then washed with 100% ethanol for 30 sec followed by sequential incubation for 30
sec in 100% ethanol, 95% ethanol, and 70% ethanol. The slides were then washed for 30
sec with distilled water and stained with hematoxylin for 30 sec. The slides were washed
with distilled water followed by sequential washes with 70% ethanol and 95% ethanol for
60 sec each. The sections were incubated in eosin solution for 30 sec, washed with 95%
ethanol for 60 sec, and then with 100% ethanol for 60 sec. The slides were incubated in
xylene for 5 min to ensure the dehydration of the sections and excess solution was
drained by touching the corner of the slide to a particle-free paper tissue. The slides were
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air-dried for 2 min to ensure the evaporation of xylene and were then used for laser
capture microdissection. The PixCell II™ LCM system (Arcturus Engineering Inc.,
Mountain View, CA) was used and proximal tubules were identified by the diagnostic
pathologist for microdissection.

The microdissected samples were collected on the

thermoplastic film of CapSure™ HS LCM caps (Arcturus Bioscience, Mountain View,
CA). Total RNA was isolated following the protocol of RNAqueous® –Micro Kit (Life
Technologies, Carlsbad CA). The thermoplastic film containing the captured proximal
tubule cells was incubated with 100 μl of lysis solution for 30 min at 42°C. Then 3 μl of
LCM additive was added to the lysate. The lysate was briefly centrifuged followed by
the addition of 1.25 volume of 100% ethanol. The lysate was passed through a pre-wetted
microfilter cartridge by centrifugation at 10,000 x g for 1 min. The filter was washed with
180 μl of wash solution and the flow- through was discarded followed by two additional
washes with 180 μl of wash solution. The flow-through was discarded and the filter was
centrifuged for 1 min to remove the residual fluid. The filter was transferred into a new
sterile tube and incubated for 5 min with 10 μl of elution solution preheated to 95°C. The
RNA was eluted by centrifugation at 13,000 x g for 1 min and used in real-time reverse
transcription polymerase chain reaction (RT-PCR).
The measurement of N-cadherin and E-cadherin was assessed using real time RTPCR and commercially available primers (Qiagen Company, Valencia, CA. Real time
PCR was performed utilizing the SYBR Green kit (Bio-Rad Laboratories) with 2 µl of
cDNA, 0.2 µM primers in a total volume of 20 µl in an iCycler iQ Real-Time Detection
System (Bio-Rad Laboratories).

Amplification was monitored by SYBR Green

fluorescence. Cycling parameters consisted of denaturation at 95ºC for 15 seconds,
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annealing at 55ºC for 30 seconds and extension at 72 ºC for 30 seconds which gave
optimal amplification efficiency of each cadherin isoform. The interpolated numbers of
transcripts from three triplicates were divided by the number of 18S rRNA transcripts and
averaged for the final reported value (± SE).
Cell Culture
Stock cultures of human proximal tubule cells (HPT) were grown using serumfree condition and collagen coated culture flasks as described previously (Detrisac et al.,
1984;Kim et al., 2002). The growth formulation consisted of a 1:1 mixture of Dulbecco's
modified Eagles' medium (DME) and Ham's F-12 growth medium supplemented with
selenium (5 ng/ml), insulin (5 μg/ml), transferrin (5 μg/ml), hydrocortisone (36 ng/ml),
triiodothyronine (4 pg/ml) and epidermal growth factor (10 ng/ml). The cells were fed
fresh growth medium every 3 days and were subcultured 1:2 at confluence (normally 3-6
days post subculture) using trypsin-EDTA (0.05% - 0.02%). HK-2 cells were obtained
from the American Type Culture Collection, expanded following recommended culture
conditions, and aliquots stored under liquid nitrogen. For studies directly comparing
properties with HPT cells, the HK-2 cells were cultured under identical growth
conditions using the serum-free growth media and subculture conditions described above
for the HPT cells. This growth condition was also used for the microarray determinations
between HK-2 cells stably transfected with the MT-3 coding sequences and the blank
vector control. To determine the effects of serum-free verses serum-contain growth
medium on the morphology and expression patterns of the HK-2 cells, the HK-2 cells
were grown to confluence on the serum-free medium as suggested by the original
publication by Ryan and coworkers (Ryan et al., 1994). At confluence, the serum-free
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growth media of the HK-2 cells was replaced by the new media formulations and 24 h
later the cells were subcultured using the new media formulations. The cells were
allowed to grow under these new conditions for a minimum of 2 passages before use in
experimental protocols.
Transepithelial Resistance
Measurement of transepithelial resistance was performed. HK-2 or HPT cells
were seeded at a 2:1 ratio in triplicate onto 24-mm-diameter cellulose ester membrane
inserts (Corning) placed in six-well trays. Beginning on the third day postseeding,
transepithelial resistance (TER) was measured every other day with the EVOM Epithelial
Voltohmmeter (World Precision Instruments, Sarasota, FL) with a STX2 electrode set
according to the manufactures instructions. The resistance of the bare filter containing
medium was subtracted from that obtained from filters containing cell monolayers and
multiplied by the surface area (available for growth) of the insert to obtain unit area
resistance. Two sets of four readings were taken at two different locations on each filter.
The development of the monolayer in parallel 12-well trays was monitored for dome
formation. The experiment was repeated twice in triplicate and the final result reported
as the mean ± SE.
RNA isolation and RT-qPCR
Total RNA was purified from cultures of HPT cells, human renal cortical tissue or
HK-2 cells utilizing TRI Reagent (Molecular Research Center, Cincinnati OH). Gene
expression was assessed with real time RT-PCR utilizing gene specific primers. Total
RNA (100 ng) was subjected to cDNA synthesis using the iScript cDNA synthesis kit
(Bio-Rad) in a total volume of 20 μl. Real-time PCR was performed utilizing SYBR
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Green (Bio-Rad) technology with 2 μl of cDNA, 0.2 μM primers in a total volume of 20
μl in an CFX real-time detection system (Bio-Rad). Cycling parameters included a 5
minute hot start followed by 40 cycles of denaturation at 94 ºC (15 s), annealing at 55 ºC62 °C (30 s), and extension at 72 ºC (30 s). Amplification was monitored by SYBR Green
fluorescence and analyzed by interpolation from a standard curve consisting of serial
dilutions of known quantities of template. Melt curve analysis confirmed the amplicon
was the dominant double stranded species and denatured at the appropriate temperature.
Protein isolation
For EMT studies, HK-2 or HPT cells were lysed in RIPA buffer containing
protease inhibitors, PMSF, and sodium orthovandate (Santa Cruz). The monolayer was
washed twice with cold phosphate-buffered saline (PBS), scraped in a small volume of
cold PBS on ice, rinsed, and pelleted at 4 °C. Pelleted cells were resuspended in an
additional volume of PBS and split in to 2-cold microfuge tubes (for parallel RNA
analysis), and pelleted. Pellets were either stored at -80 °C or

resuspended

in

cold

complete RIPA at a 1:2 w/v ratio (for every 5 mg of cell pellet, 10 uL lysis buffer) and
incubated on ice with orbital shaking for 30 minutes. The extracts were then sonicated,
placed on ice, and centrifuged at 10,000g for 10 minutes at 4°C. Supernatants were
transferred to fresh, cold microfuge tubes and either stored at -80 °C or quantified by
BCA assay (Thermo-Scientific).
For analysis of protein-protein interactions, HK-2 or HK-2(MT-3-V5) were lysed
in a more gentle lysis buffer in the attempt to limit dissociation of protein complexes.
Cell monolayers were rinsed on ice with cold PBS twice prior to the addition of 100 uL
of cold IP lysis buffer (25 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 5% glycerol, pH
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7.4) containing EDTA-free protease inhibitors (Sigma) directly to the monolayer. Plates
were incubated on ice for 30 minutes with orbital shaking, and extracts were transferred
to cold microfuge tubes and centrifuged at 10,000g for 10 minutes to pellet debris.
Lysates were transferred to fresh, cold microfuge tubes and quantified by BCA assay.
Lysates were used immediately, or stored at -80 °C.
Western Blotting
For western blotting, protein lysates were prepared in equivalent volumes to
contain 20 μg of total protein and mixed with Laemmli Buffer (Bio-Rad) containing
either TCEP or β-mercaptoethanol, and boiled for 5 minutes at 95 °C to reduce and
linearize protein. After cooling, samples were loaded onto 4-20% gradient gels (BioRad), and separated by SDS-PAGE. Proteins were transferred to 0.2 μm PVDF
membranes using the Trans-blot Turbo transfer apparatus (Bio-Rad). Following transfer,
the membranes were blocked with 5% non-fat milk or bovine serum albumin (BSA)
dissolved in 10 mM Tris-buffered saline, 0.1% Tween-20 (TBS-T) for 90 minutes at
room temperature. The membranes were incubated with primary antibodies against
(human) proteins of interest at dilutions indicated in Table II-1 overnight (16 h) at 4 °C
with orbital shaking. Membranes were washed with TBS-T, and incubated with
horseradish peroxidase conjugated secondary antibodies against the species the primary
antibodies were raised in for 1 h at room temperature with orbital shaking. Anti-rabbit
and anti-mouse antibodies were diluted 1:3000 (Cell Signaling), and the anti-goat
antibody was diluted 1:1000. Proteins of interest were visualized by chemiluminescent
HRP detection (Bio-Rad). Primary and secondary antibodies were diluted in the same
buffer used for blocking.
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Antibody
β-actin
Gelsolin
Tropomyosin
III
Myosin IIa
α-enolase
α-aldolase
V5
E-cadherin
N-cadherin
Connexin 32

Table II-1. Primary antibodies used for western blotting.
Dilution
Source &
Storage
Company
Catalog
Clonality
(ᵒC)
#
(BSA)
Mouse
-20
Abcam
Ab8226
1:1000
monoclonal
1:500Mouse
-20
Abcam
Ab11081
1:1000
monoclonal
1:1000
Mouse
4
Santa-Cruz
Sc12059
monoclonal
1:500
Goat
4
Abcam
Ab55456
polyclonal
1:3000
Rabbit
-20
Abcam
Ab56795
polyclonal
1:500
Goat
4
Santa-Cruz
Sc12059
polyclonal
1:5000
Mouse
4
Invitrogen
Ab9116
monoclonal
1:500
Rabbit
4
Santa-Cruz
Sc
polyclonal
1:1000
Mouse
-20
Life
333900
monoclonal
Technologies
1:1000
Rabbit
-20
Life
polyclonal
Technologies
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Mw
(kDa)
42
86
29-32
215
47-51
40
10-12
120
100
32

ELISA
A sandwich ELISA method was used to quantify the expression of E- and Ncadherin by the cultured cell lines. Both ELISA materials were obtained from Abnova (Ecadherin (#KA0433) and N-cadherin (Abnova, #KA1135). Plates were pre-coated with
capture antibodies against either human E-or N-cadherin. Following initial titration to
determine the appropriate net amount of protein to load per well, a range of 1-25 ug of
total protein (100 μL/well) was used for analysis. The plate was covered and incubated at
37 °C for 90 minutes (E-cadherin) or 2 hours (N-cadherin). The plate contents were
discarded and incubated with 100 μL of biotinylated polyclonal antibody against either Eor N-cadherin diluted (1:100) in antibody dilution buffer for 1 hour at 37 °C. The
contents of the plate were discarded and each well was washed three times with 10 mM
TBS.

The plate was incubated with pre-warmed avidin-biotin-peroxidase complex

(ABC) prepared 1:100 with ABC-dilution buffer at 37 °C for 30 minutes. The contents
were discarded and the plate was washed 5 times. The plate was then incubated with 90
μL of pre-warmed 3, 3′, 5, 5′ tetramethylbenzidine (TMB) substrate solution for 15
minutes at 37°C. Finally, the reaction was quenched by the addition of acidic TMB stop
solution halting the colorimetric development. The plate was then analyzed by reading
the absorbance of each well on a Biotek plate reader at 450 nm. The data was analyzed
via MasterPlex software using 5 parameter logistics to determine the amount of E- or Ncadherin present in each well.
Statistical Analysis
All experiments were performed in triplicate and the results are expressed as the
standard error of the mean. Statistical analyses were performed using GraphPad Prism®
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software using separate variance t-tests, ANOVA with Tukey post-hoc testing. Unless
otherwise stated, the level of significance was 0.05.
Stable Transfections
The HK-2 cells were transfected with wild type MT-3, MT-3 where the unique Nterminal region was altered, and MT-3 where the unique C-terminal sequence was
removed from MT-3 (Fig 1). The HK-2 cells were also transfected with MT-1E, MT-1E
where the unique C-terminal sequence of MT-3 was added to the corresponding region of
MT-1E, and MT-1E in which the sequence of the N-terminal domain was changed to the
MT-3 sequence consensus (Fig 1). The GatewayTM cloning system (Invitrogen, Carlsbad,
CA) was used for the production MT-3 site-directed mutants. The MT-3 and MT-E
coding sequences were cloned into the pENTR vector and site-directed mutagenesis was
performed by GeneScript (Piscataway, NJ). The EAEAAE sequence was deleted from
the C-terminal domain of MT-3 and this same sequence was inserted in the analogous
position of MT-1E, producing the MT-3ΔCT and 1E-CT constructs respectively. The Nterminal sequence of MT-1E (MDPNCSCA) was converted to an MT-3-like sequence
(MDPNTCPCP) for the 1E-NT construct.

For the mutagenesis of this N-terminal

sequence, the last two prolines in the above sequence were converted to threonine for the
MT-3-NT mutant. The threonine insert and prolines 7 and 9 of MT-3 were found to be
necessary and sufficient to confer growth inhibitory activity and the substitution of the
prolines to threonine is sufficient to eliminate this activity (Romero-Isart, Jensen, &
Zerbe, 2002). Each metallothionein sequence within the pENTER vector was moved to
the pcDNA6.2/V5-DEST destination vector using the Gateway™ LR recombination
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reaction. The stop codon was removed from each construct allowing for the translation of
the V5 tag on the C-terminus for alternative protein detection.
The HK-2 cells were transfected with the E-cadherin coding sequence using the
E-cadherin ORF cloned in pENTR™ 221 vector and was obtained from Invitrogen
(Invitrogen, Carlsbad, CA). The E-cadherin gene was transferred into pcDNA™6.2/V5DEST vector by LR recombination reaction (Invitrogen, Carlsbad,CA).

The DNA

constructs were linearized with BspH I and E-CDH ORF was linearized with Bcg I (New
England BioLabs, Ipswich, MA) before transfection. The HK-2 cells were transfected
using the Effectene™ transfection reagent (Qiagen, Valencia, CA) following the
manufacturer’s protocol at a ratio of 1:10 plasmid to Effectene ratio, and the lipid
complexes were added to the cells at 2 μg of DNA per 9.6 cm2 well of a 6-well culture
plate.

For antibiotic selection, transfected cells were seeded 1:10 and clones were

selected in 3 μg/ml blasticidin and clones were isolated with cloning rings and propagated
in culture medium containing 3 μg/ml blasticidin.
Transient Transfections
HK-2 cells were transiently transfected with 2 μg supercoiled V5-tagged MT-3
DNA construct (described above) using electroporation (Lonza). Subconfluent cell
cultures in the log phase of growth were trypsinized from T-75 flasks, pelleted, and
resuspended in 100 uL of room temperature Nucleofector Solution V (Lonza). Diluted
DNA was added and mixed gently before transferring the reaction to the supplied cuvette.
Electroporation program V was ran, and the entire contents of the cuvette were
transferred to 1-well of a 6-well plate containing 2 mL of 20/12. Cells were allowed 6
hours to take up the construct and to attach to the tissue culture treated matrix before the
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addition of 20/12 supplemented with 30 μM zinc. Cells were harvested 24 hours
following transfection.
Co-mmunoprecipitation
For co-immunoprecipitation of immune complexes, 1000 μg of HK-2 or HK-2 (MT-3V5) lysate was first pre-cleared by incubation with 50 μL of Protein A/G magnetic beads
(Thermo-Scientific) and rabbit IgG (to eliminate most of the non-specific protein interactions) for
30 minutes at 4°C with gentle end-over-end mixing (10 RPM). The beads were pelleted with a
magnet, and the lysates were transferred to a fresh, cold microfuge tube. Next, 20 μg of the antiV5 antibody (rabbit monoclonal, Abcam #Ab9116) was added to the tube and the total volume
was adjusted to 500 μL. The samples were incubated overnight at 4°C with gentle end-over-end
mixing (10 RPM) to allow immune complex formation. The following day, 50 μL of Protein A/G
magnetic beads were prepared by first adding 175 uL of IP lysis buffer (described above),
mixing, and removal. An additional 1 mL of IP lysis buffer was added, mixed and removed.
Immediately following the final bead wash, the immune complexes were transferred to the tubes
containing the prepared beads, and incubated at room temperature with gentle end-over-end
mixing for 75 minutes to allow the beads to capture the immune complexes. The beads were
collected, and the supernatant was removed. The beads were washed 3 times with 500 μL of 25
mM Tris-HCl, 150 mM NaCl, 0.05% Tween-20 (pH 7.4), followed by a final wash with 18Ω
H2O. Bound proteins were eluted from the antibody bound beads through incubation with
Laemmli Buffer containing no reducing agent, with mixing at room temperature for 10 minutes.
Heat causes Protein A/G to come off the magnetic beads, and reducing agent dissociate the heavy
and light chains of the antibody. Controls included were: beads + V5 antibody+ IP lysis buffer
(no lysate control); HK-2 (MT-3-V5 lysate) + beads (no antibody control); HK-2 lysate + V5
antibody + beads (no bait control) and were processed in an analogous manner simultaneously.
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CHAPTER III
RESULTS
Expression of E- and N-Cadherin in Human Kidney Proximal Tubules
To confirm the expression of E-cadherin in the proximal tubule, serial sections
were prepared from three independent specimens of human kidney in order to compare
routine H&E histology with expression of E- and N-cadherin. In proximal tubules,
staining for E-cadherin was moderate in intensity for all three specimens with staining
concentrated on the luminal or apical borders of the cells (Figure III-1 A, B; D, E; G, H).
In distal tubules, staining for E-cadherin was usually stronger than that observed for
proximal tubules and staining was present around the entire epithelial cell (Fig III-1 A, C;
D, F; G, I). In proximal tubules, staining for N-cadherin was also moderate in intensity
and often localized to the basolateral side of the tubules (Figure III-1 A, C; D, F; G, I).
Distal tubules were negative for the expression of N-cadherin (Figure III-1 A, C; D, F;
G, I). The glomeruli were negative for the expression of N-cadherin and negative to very
weakly positive for the expression of E-cadherin.
Microdissection was utilized to determine the expression of E- and N-cadherin
mRNA in proximal tubules isolated from tissue sections obtained from the three archival
specimens of human kidney. Serial sections were stained for calbindin and aquaporin to
identify that proximal tubules were selectively chosen for microdissection (Figure III2A,B
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Figure III-1. Immunohistochemical staining of E- and N-Cadherin in human
kidney.A-C: The majority of the tubules in the image are proximal tubules (A, arrow
heads). These tubules are moderately positive for E-cadherin with stronger staining on
the luminal border (B, arrow heads). Proximal tubules are also moderately positive for Ncadherin (C, arrowheads). A few of distal tubules are strongly positive for E-cadherin (B,
arrows), but negative for N-cadherin (C, arrows). On the upper right corner is a part of
glomerulus (A, +), which shows very weak staining of E-cadherin and no staining of Ncadherin (B, C, +). 200X D-F: In the center of the image is a glomerulus (D, +), which is
very weakly positive for E-cadherin (E, +) but negative for N-cadherin (F, +). Almost all
of the tubules around the glomerulus are proximal tubules, which are moderately to
strongly positive for E-cadherin, especially on the luminal or apical border (E,
arrowhead), but only weakly positive for N-cadherin (F, arrowhead). The arrows indicate
the 2 or 3 distal tubules, which are strongly positive for E-cadherin (E, arrows), but
negative for N-cadherin (F, arrows). 200X G-I: At higher magnification, it can be
clearly seen that the E-cadherin is present around the whole epithelial cells of distal
tubules (H, arrows) with stronger staining in the cell borders (H, arrows); while in
proximal tubules, E-cadherin is mainly located in the luminal borders (H, arrowheads).
For N-cadherin, it is only present in proximal tubules, and its signal is mainly located in
the basolateral sides of the tubules (I, arrowheads). Distal tubules are totally negative for
N-cadherin (I, arrows). A small part of glomerulus can be seen in upper right corner (G-I
+). X400
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Figure III-2. Expression of E- and N-cadherin in microdissected proximal tubules.
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A and B: Identification of proximal tubules by immunohistochemical staining in matched
area of normal kidney for calbindin (A)(distal) and aquaporin-1 (B) (proximal). C and D:
Verification of E-cadherin (C), N-cadherin (D) expression. The proximal tubules
(marked by *) are moderately to strongly positive for E-cadherin (mainly in the luminal
side), moderately positive for N-cadherin (mainly in basolateral side), negative for
calbindin, and diffusely strongly positive for aquaporin-1. In contrast, the distal tubules
(pointed by arrows) show diffuse, strong staining of E-cadherin and calbindin, but no
staining or faint staining of N-cadherin and aquaporin-1. The glomeruli (indicated by #)
are weakly stained by E-cadherin and aquaporin-1, but negative for N-cadherin and
calbindin. Original magnification: X200. Only one example of the serial sections is
presented, and all three specimens gave identical results. E: Expression of E- and Ncadherin mRNA in microdissected proximal tubules. RNA was purified from lasercapture microdissected proximal tubules identified in sections of formalin-fix, paraffinembedded tissue obtained from human renal cortex. Levels of RNA for E- and Ncadherin were determined quantitatively using real-time PCR and normalized to the
levels of 18S rRNA also assessed with real-time PCR. The levels of each cadherin
isoform were determined in triplicate and expressed as the number of detected cadherin
transcripts per million transcripts of rRNA. The results are expressed as the mean of
triplicate determinations (±SE). Identification of proximal tubules by
immunohistochemical staining in matched area of normal kidney for calbindin (A)
(distal) and aquaporin-1 (B) (proximal). C and D: Verification of E-cadherin (C), Ncadherin (D) expression. The proximal tubules (marked by *) are moderately to strongly
positive for E-cadherin (mainly in the luminal side), moderately positive for N-cadherin
(mainly in basolateral side), negative for calbindin, and diffusely strongly positive for
aquaporin-1. In contrast, the distal tubules (pointed by arrows) show diffuse, strong
staining of E-cadherin and calbindin, but no staining or faint staining of N-cadherin and
aquaporin-1. The glomeruli (indicated by #) are weakly stained by E-cadherin and
aquaporin-1, but negative for N-cadherin and calbindin. Original magnification: X200.
Only one example of the serial sections is presented, and all three specimens gave
identical results. E: Expression of E- and N-cadherin mRNA in microdissected proximal
tubules. RNA was purified from laser-capture microdissected proximal tubules identified
in sections of formalin-fix, paraffin-embedded tissue obtained from human renal cortex.
Levels of RNA for E- and N-cadherin were determined quantitatively using real-time
PCR and normalized to the levels of 18S rRNA also assessed with real-time PCR. The
levels of each cadherin isoform were determined in triplicate and expressed as the
number of detected cadherin transcripts per million transcripts of rRNA. The results are
expressed as the mean of triplicate determinations (± SE).xpression of E- and N-cadherin
mRNA
in
microdissected
proximal
tubules.
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Immunohistochemisstry for E-and N-cadherin verified the proximal and distal tubule
distribution seen in Figure III-1 (Figure III-2C, D). The results of this determination
showed that mRNA for both E- and N-cadherin was expressed in proximal tubule
isolated from all three independent specimens (Figure III-2E). The levels of expression
of E-cadherin varied between 2 and 7 transcripts and that of N-cadherin between 0.5 and
3 transcripts.
Expression of E- and N-Cadherin in HK-2 Cells as a Function of Growth Medium
Composition
In this analysis, the expression of E- and N-cadherin was determined on the HK-2
cell line when grown of three different growth media formulations. The first formulation
was that developed by Ryan and coworkers (Ryan et al., 1994), and suggested for use by
the ATCC, that is composed of keratinocyte serum free media supplemented with 0.05
mg/ml BPE and 5.0 ng/ml EGF (designated KSFM). The second formulation tested was
that used by Detrisac and coworkers (Detrisac et al., 1984) for the growth of human
proximal tubule (HPT) cells and is composed of a a 1:1 mixture of DME and F-12
containing selenium (5 ng/ml), insulin (5 μg/ml), transferrin (5 μg/ml), hydrocortisone
(36 ng/ml), triiodothyronine (4 pg/ml) and epidermal growth factor (10 ng/ml)
(designated 20/12EGF). The third formulation was chosen to be representative of one of
the various growth mediums used that contained fetal calf serum (Q. Li et al., 2011) and
was a 1:1 mixture of DME and Ham's F-12 growth medium containing 10% fetal calf
serum (designated 20/12FCS). In addition, it was also determined if adding 0.05 mg/ml
of BPE to the 20/12EGF formulation and if raising the calcium concentration of the
KSFM to that of 20/12 had any effect on the expression of E- and N-cadherin.
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The results of this determination showed that the expression of E-cadherin mRNA was
very low in the HK-2 cells regardless of the growth media formulation, being on the
order of 1 mRNA transcript per cell (Figure III-3A).

The corresponding matching

western blots showed only very faint bands corresponding to the expression of the Ecadherin protein (Figure III-3A). In contrast, the expression of N-cadherin mRNA was
much higher in the HK-2 cells when compared to that of E-cadherin, with most
conditions exhibiting hundreds of fold greater level of expression regardless of growth
formulation (Figure III-3B). The N-cadherin protein was also prominent on western blots
(Figure III-3B). Similar to that found for E-cadherin, the growth media composition had
little effect on N-cadherin expression. Overall, the analysis demonstrated that the HK-2
cells have a low expression of E- compared to N-cadherin and that growth media
composition has only a marginal influence on the levels of mRNA or protein expression.
Comparison of E- and N-Cadherin Expression in HK-2 and HPT Cell Cultures
The expression of E- and N-cadherin was compared between the HK-2 and HPT
cells at the level of mRNA and protein expression. Since the results of western analysis
can be influenced by the development time used to produce the blot, an ELISA-based
method was employed to quantify the amount of E- and N-cadherin that was present in
both the HK-2 and HPT cells. Three independent isolates of HPT cells were used in the
experiments and these were grown on 20/12EGF. The HK-2 cells were grown on KSFM,
20/12FCS, and 20/12EGF. The results of this analysis confirmed that the HPT cells
produced E-cadherin mRNA in substantially higher amounts than the HK-2 cells
regardless of growth media composition (Figure III-4A). The levels of E-cadherin mRNA
in

HPT

cells

was

over

50

fold

higher
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than

levels

in

HK-2

cells.

Figure III-3. Influence of growth medium on E- and N-cadherin expression HK-2
cells. A) E-cadherin mRNA expression in HK-2 cells grown in various growth media.
Expression was assessed with real-time RT-PCR and expressed as the number of
transcripts per million transcripts of β-actin. Western analysis of E-cadherin is shown
below the graph. See Materials and Methods for media formulations. B) N-cadherin
mRNA expression in HK-2 cells grown in various growth media. Messenger RNA
expression was assessed by real-time PCR. Western analysis of N-cadherin is shown
below the graph.

This difference in mRNA expression did translate to the amount of E-cadherin protein,
with ELISA analysis showing a similar large (>50 fold) increase in E-cadherin protein in
the HPT cells compared to the HK-2 cell line (Figure III-4B). An identical analysis of Ncadherin expression confirmed that N-cadherin mRNA expression was higher in the HK2 cell line compared to the HPT cells (Figure III-5A). An analysis of N-cadherin protein
expression also demonstrated that this difference did translate to the differences in the Ncadherin protein (Figure III-5B).
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Figure III-4. Comparison of E-cadherin expression in HPT and HK-2 cell cultures.
A) Expression of E-cadherin mRNA in three independent HPT isolates (human proximal
tubule cells) compared to that in HK-2 cells growth in three different media formulation.
HPT cells were grown in the 20/12EGF formulation. B) Levels of E-cadherin protein
measured quantitatively using an ELISA. C) Western analysis of E-cadherin in the
identical cultures as in A and B. Significant differences between HK-2 and each HPT
isolate are designated ***p < 0.0001, of ** p< 0.001 as determined by one-way ANOVA
with Tukey’s post-hoc test.
However, the magnitude of the difference between N-cadherin protein expression
between the HPT and HK-2 cell lines was much less (4 to 10 fold) than that found for the
E-cadherin protein (Figure III-4B versus III-5B). Overall, the results demonstrate that the
level of E-cadherin mRNA and protein is significantly higher in HPT cells compared to
HK-2 cells and that the expression pattern is reversed for the expression of N-cadherin
between the cell lines. To validate that HK-2 cells grown on filters did not alter their E-
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cadherin levels, protein extracts were taken from the cells on the filter inserts and
subjected to western analysis for both E- and N-cadherin protein expression. The results
of this experiment show that the expression level of these cadherins was not altered from
culturing in the filter-insert environment (III-6).

Figure III-5. Comparison of N-cadherin expression in HPT and HK-2 cell cultures.
A) Expression of N-cadherin mRNA in three independent HPT isolates (human proximal
tubule cells) compared to that in HK-2 cells growth in three different media formulation.
HPT cells were grown in the 20/12EGF formulation. B) Levels of N-cadherin protein
measured quantitatively using an ELISA. C) Western analysis of N-cadherin in the
identical cultures as in A and B.
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Figure III-6. The pattern of E-and N-cadherin expression is unaltered when cells are
grown on transwell inserts. Growing cells on trawnswell inserts allows both the apical
and basolateral membranes of proximal tubule cells to have access to the growth medium,
a situation that is a better model of proximal tubule transport in vivo that tissue culture
treated plastic substrates. E- and N-cadherin expression remains very similar in both
growth conditions.
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Alterations in Tight Monolayer Development
The transepithelial resistance of the HK-2 and HPT cell monolayers was also
determined to confirm that the growth media composition had no effect on the tight
junctions between the cells. It was shown that the HK-2 developed no transepithelial
resistance (TER), whereas, the HPT cell line developed a TER consistent with a “leaky”
epithelium (Figure III-7).

Figure III-7. Transepithelial resistance comparison of HPT and HK-2 cell cultures.
Cells were grown on filter supports and the electrical resistance across the monolayer was
measured. Resistance is expressed as Ohms-cm2. Three independent HPT isolates
(human proximal tubule cells) are compared to that in HK-2 cells growth in three
different media formulation. HPT cells were grown in the 20/12EGF formulation.
Significant differences between HK-2 and each HPT isolate are designated *p < 0.0001
as
determined
by
one-way
ANOVA
with
Tukey’s
post-hoc
test.
As a further validation for an alteration in cell-to-cell junctions, the HK-2(MT-3),
HK-2(blank vector) and HPT cells were assessed for the expression of connexin 32. The
results of this determination showed that HK-2(BV) had marginal expression of connexin
32 mRNA and protein, while the HK-2(MT-3) and HPT cells each showed significant
expression of both connexin 32 mRNA and protein (Figure III-8). These finds further
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validate the findings of altered cell-to-cell junctional responsibilities between the HK-2
and the HPT cell line and extend those observations to communication between adjacent
cells.

Figure III-8. Connexin 32 expression in HK-2, HPT, and HK-2 cells expressing MT3. Messenger RNA of connexin 32 was assessed with real-time PCR and expressed as a
fold increase of the HK-2 cells stably transfected with the blank vector. The change in
connexin 32 expression was normalized to the change in β-actin expression. Western
analysis of connexin 32 is shown below the graph.
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Association of the Unique C-Terminal Domain of MT-3 With MT-3 Induced
MET in HK-2 Cells
The goal of this experiment was to determine the functional domain of the MT-3
protein required for the MT-3 protein to re-establish vectorial active transport, produce an
enhanced epithelial morphology, elicit a shift in the expression of E- and N-cadherin, and
to increase the expression of connexin 32. Four constructs were used to transfect the HK2 cells to determine their effect (III-9) on vectorial active transport as judged by the
appearance of domes and the generation of a transepithelial resistance.

The first

construct was MT-3 where the N-terminal sequence was been mutated, the second was
MT-3 where the C-terminal sequence was mutated, the third was the MT-1E isoform
where the unique C-terminal sequence of MT-3 was inserted into the sequence, and the
fourth was the MT-1E isoform where the unique N-terminal sequence of MT-3 was
inserted into the sequence. The HK-2 cell line carrying the blank vector or transfected
with the MT-1E isoform served as controls. The results of this determination
demonstrated that the C-terminal sequence of MT-3 is required for the establishment of
vectorial active transport when MT-3 is transfected and expressed in the HK-2 cell line.
First, the mutation of the N-terminal sequence of MT-3 had no effect on the ability of
HK-2 cells to form domes or generate a transepithelial resistance (Figure III-10 A,B;
Table III-1).
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Figure III-9. Mutated metallothionein constructs. A) Amino acid sequence of human
MT-3 compared with human MT-1E. Shown in red are the MT-3 specific sequences that
are not exhibited in any mammalian MT 1/2 isoform. The N-terminal TCPCP sequence
of MT-3 has been shown to confer the unique biological activity of neuronal growth
inhibitory activity [38]. These two sequences were independently deleted from MT-3
and inserted into the MT-1E isoform to test for the conference of vectorial active
transport. B) Schematic diagram of the various metallothionein constructs with: MT-3
denoting the wild-type sequence; MT-3-ΔNT, the two essential prolines were converted
to threonines; MT-3ΔCT, the EAAEAE C-terminal sequence was deleted from MT-3;
MT-1E, wild-type 1E isoform of metallothionein; 1E-NT, the N-terminal sequence of
MT-3 was inserted into the corresponding position of MT-1E; 1E-CT, the MT-3 Cterminal sequence EAAEAE was inserted into the corresponding position of MT-1E.
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Figure III-10: Effect of the altered domains of MT-3 on the formation of domes in
stably transfected HK-2 cells. To assess the domain of MT-3 that is responsible for the
ability to confer dome formation, site-directed mutants of MT-3 were produced and the
two unique domains of MT-3 were inserted into the non-doming MT isoform, MT-1E, as
shown in Figure 1. Each expression construct was stably transfected into HK-2 cells, and
expressing clones were assessed for the ability to form domes. A) wild-type MT-3
showing dome formation when stably transfected, B) MT-3-ΔNT where the prolines in
the N-terminal domain that confers growth inhibitory activity were converted to
threonines, show that the ability to form domes was not compromised, C) MT-3ΔCT
where the C-terminal EAAEAE sequence unique to the third isoform of metallothionein
was deleted, shows the lack of dome formation, D) MT-1E, wild-type human
metallothionein 1E, commonly expressed at high levels in many cell types exhibits no
domes when stably transfected, E) 1E-NT, the N-terminal unique sequence of MT-3 was
inserted into the corresponding position of MT-3 shows no conference of dome
formation, and F) 1E-CT, the EAAEAE sequence of MT-3 was inserted in the
corresponding position of MT-1E and when stably transfected into HK-2 cells confers
dome formation.
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In contrast, mutation of the C-terminal sequence of MT-3 abolished both dome formation
and the transepithelial resistance of the monolayer (Figure III-10 A,C; Table III-1). The
MT-1E isoform of MT does not contain either of the unique C-terminal or N-terminal
sequences of MT-3 and transfection of HK-2 cells with MT-1E do not form domes in
culture or develop a transepithelial resistance (Figure III-10D). The insertion of the Nterminal sequence of MT-3 into the MT-1E gene and subsequent transfection into the
HK-2 cells does not result in dome formation or the development of transepithelialelectrical resistance (Figure III-10E, Table III-1).
In contrast, the insertion of the C- terminal sequence of MT-3 into the MT-1E
gene and subsequent transfection into the HK-2 cells results in both dome formation and
the generation of a transepithelial resistance (Figure III-10F; Table III-1).
The expression of E- and N-cadherin in HK-2 cells transfected with each MT-3
mutant construct was assessed (Figure III-11). Those constructs that produced domes in
culture expressed high levels of E-cadherin. Constructs containing only the N-terminal
domain of MT-3 were also able to highly express E-cadherin, despite the lack of the
ability to form domes. The repression of N-cadherin, however, required the presence of
the C-terminal domain (Figure III-11). The expression of connexin 32 required the
presence of both domains with each domain being able to support intermediate levels of
connexin 32 (Figure III-12).
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Figure III-11. Effect of the altered domains of MT-3 on the expression of E-and Ncadherin in stably transfected HK-2 cells. Messenger RNA of E-cadherin (A) and Ncadherin (B) were assessed with real-time PCR and expressed as fold change in
expression versus HK-2 cells transfected with the blank vector. The change in E- or Ncadherin expression was normalized to the change in β-actin expression. Significant
differences from HK-2 (BV) are designated as ** p < 0.001,*** p < 0.0001. Western
analysis of E-cadherin (C) and N-cadherin (D) was conducted in identical cultures as in A
and B. β-actin was used as a loading control and for densitometric normalization.
Densitometry is shown below the corresponding blot.

51

Figure III-12. Effect of the altered domains of MT-3 on the expression of connexin
32 in stably transfected HK-3 cells. A) Messenger RNA of connexin 32 assessed with
real-time PCR and expressed as fold change in expression versus HK-2 cells transfected
with the blank vector. The change in connexin 32 expression was normalized to the
change in β-actin expression. Significant differences from HK-2 (BV) are designated as
*** p < 0.0001. B) Western analysis of connexin 32 was conducted in identical cultures
as in (A). β-actin was used as a loading control and for densitometric normalization.
Densitometry is shown beside the corresponding blot.
Effect of Forced E-cadherin Expression on HK-2 Vectorial Active Transport,
N-Cadherin Expression, and Cell Morphology
It was previously shown that the stable transfection of HK-2 cells with MT-3
resulted in the re-establishment of vectorial active transport with a corresponding
induction of E-cadherin and repression of N-cadherin gene expression [30]. In this study
E-cadherin was transfected into the HK-2 cells to determine if the expression of Ecadherin, in the absence of MT-3 expression, could restore vectorial active transport. It
was also determined if E-cadherin expression would alter cell morphology or the
expression of N-cadherin in the HK-2 cells. Five independent clones were selected and
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characterized for their expression of E-cadherin mRNA and protein. Two clones (5 and
15) displayed an elevated expression of E-cadherin, two displayed a very modest
elevation (3 and 14) and one (9) displayed no detectable alteration in expression of Ecadherin mRNA and protein (Figure III-13A,C). An analysis of N-cadherin mRNA
expression showed that N-cadherin expression was highly repressed in the two isolates of
HK-2 cells that expressed an elevated level of E-cadherin expression (Figure III-13A,B).
N-cadherin mRNA was modestly repressed in the two isolates of HK-2 cells that
expressed very modest elevation of E-cadherin expression (Figure III-13A,B). There was
no alteration in the level of N-cadherin mRNA from that found in HK-2 cells for the
transfected HK-2 cell clone (#9) that failed to increase their level of E-cadherin (Figure
III-13A,B).

The correlation between the expression of E-cadherin mRNA and the

repression of N-cadherin mRNA was not as pronounced for the corresponding proteins
(Figure III-13C). In agreement with the mRNA expression data, it was shown that
whenever E-cadherin protein was expressed, there was no expression of the N-cadherin
protein. The results also demonstrated that transfection of the HK-2 cells with E-cadherin
did not result in the re-establishment of vectorial active transport as evaluated by both
dome formation and the development of a transepithelial resistance across the monolayer.
None of the 5 independent clones showed any evidence of dome formation by the cell
monolayers or developed a transepithelial resistance above a blank filter control (data not
shown). The morphology of the cells was also not altered by transfection of E-cadherin
into the HK-2 cell lines as noted by a similar morphology between wild type HK-2 cells
and clone 5 which had the highest level of E-cadherin protein expression (Figure III13D,E).

This result also correlates with constructs containing the N-terminal but
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lacking the C-terminal domain being able to support E-cadherin expression but not
sufficient enough to establish vectorial active transport (Figure III-11, Table III-1).

Figure III-13. The effect of forced overexpression of E-cadherin on the expression
of N-cadherin and on dome formation in HK-2 cells. E-cadherin was stably
transfected into the HK-2 human proximal tubule cell line and individual clones were
isolated and assessed for E-cadherin and N-cadherin expression and the formation of
domes. A) Expression of E-cadherin mRNA in five individual clones, HK-2 cells and
the MT-3 stably transfected HK-2 line, HK-2 (MT-3) assessed quantitatively with realtime PCR and normalized to the levels of transcripts of glyceraldehyde phosphate
dehydrogenase; B) Expression of N-cadherin mRNA; C) Expression of E- and Ncadherin protein in each isolated clone, D) and E) Morphology of the highest expressing
E-cadherin clone (E) in comparison to the parental HK-2 cells (D) showing the absence
of dome formation.
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Zn7MT-3 mediated pulldowns in HK-2 lysates
In order to identify potential protein interactions of MT-3 within the human
proximal tubule, Zn7MT-3 was covalently crosslinked to amine-reactive agarose beads
and incubated with lysates isolated from HK-2 cells (Figure III-14). Previous studies
indicated β-actin, myosin IIa, gelsolin, and tropomyosin 3 as putative binding partners
(Bathula, 2010).

Literature review indicated enolase-1 and aldolase-A as MT-3

interacting proteins in cultured astrocytes (Armitage, 2010), and these potential
interactions were also evaluated. Eluates were subjected to SDS-PAGE followed by
western blotting, probing for potential MT-3 interacting proteins. The results of this
determination showed Zn7MT-3 able to pulldown β-actin, tropomyosin-3, α-enolase, and
aldolase-a from HK-2 lysates (Figure III-15).
V5-mediated immunoprecipitations in MT-3 expressing HK-2 lysates
To further support the protein-protein interactions observed through pulldowns, we
generated mutant cell lines either stably or transiently expressing MT-3 with a protein tag
(V5). The MT-3 antibody is generated against the C-terminal insert not present in the
other isoforms. We have hypothesized the C-terminal domain of MT-3 to be the region
of protein-protein interactions, as this feature distinguishes MT-3 from MT-1,-2, and -4.
This becomes problematic for co-immuoprecipitation if this domain is blocked by the
interactions in which we are attempting to determine. For these reasons, the stop codon of
MT-3 was removed in order to allow translation of a V5 tag to aid in
immunoprecipitation , western blotting, and immunofluorescence. V5 is a relatively
small tag in comparison to most other commercially available protein tags, adding an
additional 4 kDa. Prior to performing immunoprecipitation, lysates were tested for the
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Figure III-14. Schematic representation of the methodology used to pulldown MT-3
interacting proteins. Eluted fractions were subjected to silverstaining to confirm the
presence of proteins of the correct molecular weight and western blotting to confirm the
identity of these previously identified proteins.
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Figure III-15. MT-3 interacts with β-actin, Tropomyosin 3, enolase-1, and aldolase
A. MT-3 can pulldown proteins isolated from cultured human proximal tubule cells,
suggesting potential protein interactions between MT-3 and B-actin (A), Tropomyosin-3
(B), alpha-enolase (C), and aldolase-a (D) in the human proximal tubule.

Figure III-16. Zinc supplementation 6 hours post transient transfection of V5tagged MT-3 into HK-2 cells increases MT-3 protein expression. V5 tagged-MT-3
migrates at the appropriate molecular weight, and zinc supplementations following
transfection yields more available V5 tagged-MT-3 available for coimmunoprecipitation.
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presence of MT-3 –V5 by western blotting (Figure III-16) . We also confirmed the lack
of V5 signal in MT-3 null lysates. Interestingly, cells supplemented with 30 uM zinc in
the growth medium six hours-post transient transfection contained more MT-3 protein
than those supplemented with the normal growth medium (Figure III-17). MT-3 is not
inducible by zinc, so this observation probably correlates to the increased stability of
fully zinc-bound MT-3 than apo-MT-3 or less metallated forms of MT-3, resulting in less
turnover of this protein.

The eluates were subjected to SDS-PAGE followed by

silverstaining to test for the presence of proteins in the eluted fractions, and that proteins
were present in the eluate that migrated at the approximate molecular weight of those
proteins previously identified in 2010 (Figure III-17).

Figure III-17. MT-3 interacts with several proteins in cultured proximal tubule
cells. Representative image of a silverstained gel following SDS-PAGE of eluates from a
pulldown experiment. Arrows indicate proteins present at the molecular weight of
putative interacting proteins identified by Bathula in 2010.
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Co-immunoprecipitation of V5-MT-3 complexes and subsequent western blotting
confirmed β-actin, myosin IIa, enolase-1, and possibly aldolase-a (Figure III-18) as
potential MT-3 interacting proteins in the proximal tubule.

Figure III-18. Co-immunoprecipitation of MT-3 protein complexes in HK-2 cells
transfected with V5 tagged-MT-3. V5-tagged MT-3 immunoprecipitates with myosin
IIa, β-actin, and enolase-1. Lane 1 and 2 are the lysate inputs used for coimmunoprecipitations, Lane 3 is the eluate from the control reaction that contained all the
reaction components (e.g. Protein A/G magnetic beads, V5 antibody, IP lysis buffer)
excluding cellular lysate; Lane 4 is the control reaction that contained all reaction
components excluding the V5 antibody; Lane 5 is the no prey control, containing all
reaction components as lane 6 but incubated with non-transfected HK-2 lysate. Equal
volumes were loaded into each lane.
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CHAPTER IV
DISCUSSION
HK-2 Cells have Features Associated with the Initial Stages of EMT
EMT is a developmental process where reorganization of the actin cytoskeleton, a
loss of apical-basolateral polarity, and loss of cell-to-cell contact, results in conversion of
an epithelial cell to a mesenchymal cell. The repression of the epithelial marker, Ecadherin, and upregulation of the mesenchymal marker, N-cadherin, are gene expression
changes typically observed during EMT (Wu, Tsai, Wu, Teng, & Wu, 2012). As detailed
in the introduction, the HK-2 cell line has seen frequent use as a model to study the
process of EMT in the human kidney. This laboratory previously reported that the HK-2
cell line had a very low expression of E-cadherin compared to N-cadherin, an absence of
tight junction mediated paracellular barrier function, and a failure to maintain vectorial
active transport (Bathula et al., 2008; Kim et al., 2002). These would be features that
suggest that the HK-2 cell line may have undergone an appreciable level of EMT during
the isolation of the cell line. However, these studies used one of a variety of growth
media employed for growth of the HK-2 cell line and therefore may not have been
representative of other reports in the literature that use this cell line. Thus, the first goal
of the present study was to confirm the levels of expression of the E- and N-cadherin,
tight junctional integrity, and vectorial active transport in the HK-2 cell line as a function
of

growth

media

composition..

The

results

of

this

study

confirmed that the HK-2 cells expressed a very low amount of E-cadherin mRNA and
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protein and that this expression was largely independent of the composition of the growth
media. Similarly, the expression of N-cadherin was very high compared to that of Ecadherin. The HK-2 cell monolayer exhibited no transepithelial resistance on any of the
growth media tested, confirming a lack of tight junctional integrity.

It was also

demonstrated that the HK-2 cell line did not form “domes”, a feature of vectorial active
transport, on any of the tested growth mediums. The formation of domes is a hallmark of
cultured renal epithelial cells that retain the in situ property of vectorial active transport
(D. A. Sens et al., 1999). These out-of-focus areas of the cell monolayer, seen upon light
microscopic examination, represent raised areas where fluid has become trapped
underneath the monolayer owing to active transport of ions and water across the cell
monolayer in an apical to basolateral direction. These results show that the HK-2 cell
line, regardless of the conditions used for growth, have a low expression of E- compared
to N-cadherin, an absence of tight junctions, and do not form “domes”.
There is agreement in the literature that the renal proximal tubule does express Ncadherin in line with a developmental derivation from mesenchyme (Jung, Dean, Jiang,
& Gaylor, 2004; Nürnberger & Feldkamp, 2010; W. Prozialeck et al., 2004; Shimazui &
Kojima, 2006). However, the literature is somewhat less clear regarding the expression
of E-cadherin. In the developing kidney, it has been shown that the early progenitors of
the proximal tubules express cadherin 6 and not E-cadherin (Cho, Patterson, &
Brookhiser, 1998). Then, as the proximal tubules mature, cadherin-6 (also called Kcadherin) is down-regulated and E-cadherin is then detected in the mature proximal
tubules of the adult kidney (Cho et al., 1998). In this regard, cadherin-6 can be looked
upon as a marker for the fetal proximal tubule. Despite this convincing study, there is
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some discrepancy in the literature regarding the expression of E-cadherin in the proximal
tubule, with some reports indicating no expression (Docherty & Calvo, 2009; Esteban,
Tran, & Harten, 2006; Nouwen & Dauwe, 1993; Nürnberger & Feldkamp, 2010;
Shimazui & Kojima, 2006), others low expression well below that of N-cadherin (Huby,
Rastaldi, & Caron, 2009; Langner, Ratschek, & Rehak, 2004; Mori, Lee, & Rapoport,
2005; W. Prozialeck et al., 2004; Walter C Prozialeck et al., 2003), and some with
expression without indication of level (Alami, Williams, & Yeger, 2003; Piepenhagen &
Nelson, 1998). Due to this discrepancy in E-cadherin expression, the present study
examined the expression of E- and N-cadherin in the human kidney proximal tubule. It
was shown using immunohistochemistry on three independent specimens of human
kidney that the proximal tubules had expression of both E- and N-cadherin protein. The
study was also extended to the level of mRNA expression by microdissection of proximal
tubules from 3 independent specimens and determining the expression of E- and Ncadherin by real time PCR. It was found that there was expression of both E- and Ncadherin mRNA in the proximal tubules.

The proximal tubules chosen for

microdissection were those in close proximity to glomeruli, greatly minimizing any
chance for contamination with other types of tubular elements. A plausible reason for the
discrepancy in the literature regarding the expression of E-cadherin in the proximal
tubule is that most studies relied on immunohistochemistry, both peroxidase and
fluorescent based, in attempts to detect and compare the intensity of staining between
antibodies for E- and N-cadherin. While it is possible to compare the intensity of staining
within each antibody across the differing elements of the kidney, it is not possible to
compare the intensity of staining generated between the E- and N-cadherin antibodies and
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draw conclusions regarding levels of expression.

Each antibody will have its own

characteristics of antigen binding and staining can also vary further between antibodies as
a function of tissue fixation, antigen retrieval techniques, and incubation conditions to
name but a few variables. It is extremely difficult, if not impossible, to compare the level
of expression of E-cadherin to N-cadherin using immunohistochemical analysis. Thus,
the present study shows that both E- and N-cadherin mRNA and protein are expressed in
the human renal proximal tubule.
The present results suggest that the HK-2 cell line has already undergone an
appreciable degree of EMT. This is based on several observations. First, the HK-2 cell
line does not form “domes” in cell culture. This is in contrast to primary cultures of
human renal epithelial cells, isolated and cultured by several different laboratories that
have been shown to form “domes”(KEMPSON, 1986; Wilson & Dillingham, 1985), [56],
(Detrisac et al., 1984). In fact, the primary culture used in the isolation of the HK-2 cell
line was stated to form “domes” prior to being used in the transfection and
immortalization procedure (Ryan et al., 1994). Dome formation in epithelial cell cultures
is acceptable presumptive evidence of the following processes that are required for its
expression: functional plasma membrane polarization, formation of occluding junctions
(tight junctions), and vectorial transepithelial active ion transport [57]. Studies from this
laboratory demonstrated that the HK-2 cell line does not generate a transepithelial
electrical resistance or possess tight junctional sealing strands, both indicative of a loss of
tight junctions between adjacent cells (Kim et al., 2002). Second, the present study
confirms that the HK-2 cell line has undergone an E-cadherin to N-cadherin shift when
compared to the HPT cells. The present study quantified the difference in E-cadherin and
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N-cadherin between the HPT and HK-2 cells. This showed high levels of E-cadherin in
the HPT cells and very low levels in the HK-2 cell line. The reverse was shown for Ncadherin expression, but the magnitude of the difference was not as large. In addition,
when compared to the HPT cells, the HK-2 cell line has increased expression of
cadherin-6 (K-cadherin), a marker associated with the proximal tubule of the developing
kidney (Bathula et al., 2008; Cho et al., 1998).

This finding suggests a more

mesenchymal differentiation of the HK-2 cells based on the known development of the
proximal tubule (Cho et al., 1998). Third, the human proximal tubule is known to
possess gap junctions between adjacent cells. The present study demonstrated that the
HPT cells expressed connexin 32; whereas, the HK-2 cell line had a very reduced
expression of this connexin. Thus, the present results suggest that the HK-2 cells already
displays those features of a cell having undergone appreciable EMT.
The results should not be interpreted to indicate that the HK-2 cell line is an
unacceptable model for the study of the overall process of EMT. Too often EMT is
looked upon as an all-or-none process rather than a graded series of events. The HPT cell
line and all other primary mortal cultures of cells retaining proximal tubule character
have lost their brush border. This could be looked upon as a very early feature of EMT
that occurs upon placing the cells into culture. Similarly, the HK-2 cell line could be
looked upon as a model for a proximal tubule cell that has lost early features associated
with EMT such as cell-to-cell contact, a loss of apical to basolateral separation and
cadherin switching. However, the HK-2 cells retain many other differentiated features of
the proximal tubule. As detailed in the introduction, these include: proteins such as
alkaline phosphatase, gamma glutamyltranspeptidase, leucine aminopeptidase, acid
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phosphatase, cytokeratin, α3β1 integrin and fibronectin; and functional markers such as,
the cAMP responsiveness to parathyroid hormone but not antidiuretic hormone, Na+dependent, phlorizin-sensitive glucose transport, and the ability to accumulate glycogen.
As such, the HK-2 cell line could be looked upon as a model system where EMT has
progressed with regard to a loss of cell junctions and the E- to N-cadherin switch, but
with the retainment of many features of proximal tubule differentiation. The HK-2 cell
line may be very valuable in elucidating pro-fibrotic factors and in defining the changes
necessary for the HK-2 cells to gain further mesenchymal differentiation.
There is also convincing evidence that the differences between the HPT and HK-2
cell line is not an anomaly of the isolation protocol used to develop the HK-2 cell line.
The HK-2 cell line is derived from a single clone of cells following transfection with the
HPV E6/E7 genes as designated in the ATCC product sheet and the original publication
(Ryan et al., 1994) . Thus, a simple explanation for the finding that HK-2 cells have no
tight junctions and have undergone an E- to N-cadherin switch is that the HK-2 cell line
was derived from an aberrant single cell that possessed these properties in the original
primary culture used for isolation of the cell line. Under this scenario, the originating cell
would not have been representative of the cells within the primary culture that were able
to form domes. However, if the above were the case, the HK-2 cell would not be
expected to be able to undergo MET and regain the original characteristics of the cells of
the primary culture that are able to form domes.
HK-2 Cells Undergo MET Mediated by MT-3
Studies from this laboratory have shown that the HK-2 cells can undergo MET
and regain the features expected of primary cultures of human proximal tubule cells
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(Bathula et al., 2008; Kim et al., 2002). This was accomplished by the stable transfection
of the MT-3 gene into the HK-2 cell line. The HK-2 cells transfected with the MT-3
gene regained the ability to form domes in culture, displayed increased transepithelial
resistance, and a switch from N-cadherin to E-cadherin expression. The present studies
also demonstrated that the MT-3 transfected cells regained the expression of the gap
junction protein connexin 32, similar to that found in primary cultures. These studies
show that the HK-2 cell line can undergo MET and convert back to those phenotypic and
genotypic properties of the original primary culture. In addition, the ability of the MT-3
gene to induce MET in HK-2 cells provides a model for the study of MET in the
proximal tubule and also might uncover mechanistic approaches to halt the pro-fibrotic
microenvironment of the kidney if it indeed wholly or partially develops from EMT of
tubular epithelium. There appears to be many more models for the study of renal EMT
than that of MET in the adult kidney.
The finding that MT-3 elicited MET-like changes in HK-2 cells was not based on
a mechanistic hypothesis regarding EMT or MET. Rather, the laboratory was studying
the possible role of the MT-3 gene in cadmium-induced renal toxicity. There is no other
existing literature to suggest a role of MT-3 in renal EMT or MET. There is also no
literature on how MT-3 might interact with the HPV E6 and E7 genes to promote MET in
HK-2 cells. However, MT-3 has two unique sequences that help define the epitope of its
participation in EMT and MET. The MT-3 isoform is unique among the MT gene family
and these differences from other family members have been highlighted in past reports
from this laboratory (Bathula et al., 2008; Kim et al., 2002; Seema Somji et al., 2004).
Of importance in the present study is that MT-3 possesses 7 additional amino acids that
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are not present in any other member of the MT gene family, a 6 amino acid C-terminal
sequence and a Thr in the N-terminal region (Palmiter, 1992; Tsuji, Kobayashi, &
Uchida, 1992; Uchida et al., 1991). The current study shows that a unique C-terminal
amino acid insert of MT-3 was required to re-establish vectorial active transport and the
shift in E- and N-cadherin expression for the HK-2 cells. This would be the first study to
define a functional significance to this unique sequence of the MT-3 protein. The only
other study was one designed to define how the C-terminal insert in MT-3 would alter
metal binding characteristics compared to other members of the MT gene family (Zheng,
Yang, Yu, & Cai, 2003). This study demonstrated that the C-terminal hexapeptide insert
would lower the stability of the MT-3 α-domain metal-thiolate cluster; an alteration that
would render the metal binding site more accessible for metal exchange with potential
protein partners. Overall, the present study demonstrates the essential nature of the Cterminal sequence by both deletion of the sequence from the MT-3 gene and by insertion
of the sequence into the MT-1E isoform, which resulted in the loss of dome formation
and the establishment of dome formation in transfected HK-2 cells, respectively.
MT-3 Interacts with Proteins that Promote an Epithelial Phenotype
The regulation of cytoskeletal organization is an important feature for polarized
epithelial cells; apical-basolateral polarity is vital for vectorial active ion transport,
intercellular communication, tissue organization, and general cellular homeostasis. Cells
that lose lateral cell-cell contacts display impaired cell polarity. Further, formation of
lamellipodia protrusions is crucial step in the acquisition of migration. Under normal
physiological conditions, homeostasis is promoted by the maintenance of cytoskeletal
organization and essential structural components that promote cell shape while also
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facilitating cell-cell and cell-extracellular matrix anchorages.
Myosin-IIA is a member of the type II non-muscle myosin family of proteins and
is coded for by the MYH9 gene. This isoform is a conventional heavy chain containing
an IQ domain and a myosin-head like domain that is intricately involved in regulation of
the actin cytoskeleton, affecting cytokinesis, cell motility, and maintenance of cell shape.
Defects in the MYH9 gene have been associated with several types of CKD including
sickle

cell

disease

nephropathy,

chronic

glomerulonephritis,

focal

segmental

glomerulonephritis, diabetic and non-diabetic nephropathies (Ashley-Koch et al., 2011;
Cooke et al., 2012; Kao et al., 2008; Kopp et al., 2008; Singh, Nainani, Arora, & Venuto,
2009). During the initiation of cell migration, cells extend their plasma membranes in the
form of lamellipodia that requires cytoskeletal reorganization.

During this process

monomeric G-actin polymerizes into F-actin filaments and is reorganized and
depolymerized. Non-muscle myosin II associates with F-actin, and is known to generate
contractile forces and tension. There are three-Type II non-muscle myosin members,
myosin IIA, IIB, and IIC, coded for by MYH9, MYH10, and MYH14 respectively.
Myosin IIA appears to have an opposite function to myosin IIB, acting to confer
contractile and retrograde force at the cell margin while IIB confers protrusive force at
the cell margin (Betapudi, 2010). Myosin IIa may play a role in the prevention of cell
migration, promoting the maintenance of epithelial cell shape though cytoskeletal
organization,
Tropomyosin alpha-3 chain, coded for by TPM3, binds to actin filaments in both
muscle and non-muscle cells. In non-muscle cells tropomyosin-3 stabilizes cytoskeletal
actin filaments and regulate the access of the other actin binding proteins. Tropomyosin-
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3 is protective against actin filament depolymerization. Additionally, this protein has
been found at the brush border of epithelial cells of the intestine and kidney, and is not
found in association with the leading edge migratory lamellipodia, but rather at the base
or rear portion. Tropomyosin prevents myosin IIB access to the actin filament, which
antagonizes the pro-migratory action of myosin IIB. Working together, tropomyosin-3
and myosin IIA aid in the maintenance of the actin cytoskeleton promoting epithelial cell
polarity, a feature we propose MT-3 to contribute to in human proximal tubule cells.
Enolase-1, coded for by the ENO1 gene, is a metal activated enzyme that
catalyzes the dehydration of 2-phosphoglycerate to phosphoenolpyruvate in glycolysis.
There are three isoforms of enolase including non-neuronal enolase (enolase-1 or αenolase); neuron-specific enolase (enolase-2 or γ-enolase); and muscle-specific enolase
(enolase-3 or β-enolase). These proteins occur as dimers, with the two monomer subunits
orient in an antiparallel manner.

The dimerization process is dependent on two

magnesium ions, and these divalent cations play a critical role in catalysis (Díaz-Ramos,
2012). These enzymes also bind strongly to zinc ions, however enzyme activity is
decreased when bound to these divalent cations (Ghazi et al., 2010). Enolase-1 occurs
only as a homodimer (αα), is localized predominantly to the cytoplasm, but can also
translocate to the apical plasma membrane and act as a plasminogen receptor.
Overexpression of enolase has been associated with a plethora of diseases ranging from
AD, cancer, as well as autoimmune diseases rheumatoid arthritis and primary
nephropathies from lupus nephritis.(Bruschi et al., 2014).

Enolase-1 has also been

demonstrated to bind to F-actin microtubules (Walsh, Keith, & Knull, 1989).
α-enolase

Further,

knockdown in tumor derived cell lines increased their sensitivity to
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microtubule targeted drugs (Georges, Bonneau, & Prinos, 2011). With respect to MT-3
interactions with enolase-1, it is possible that MT-3 is acting as a zinc donor to facilitate
homodimer formation , metal exchange to reduce the enzyme activity, or participating
thiol-disulfide exchange (Meloni et al., 2007).
Aldolase A, coded for by ALDOA gene, is an enzyme that catalyzes the
conversion

of

fructose-1,6-bisphosphate
in

glycolysis

to

glyceraldehyde
(and

the

reverse

3-phosphate
reaction

and

dihydroxyacetone

phosphate

during

gluconeogenesis).

Aldolase-A has been demonstrated to directly interact with both F-

actin and enolase-1 (Walsh et al., 1989). Aldolase-A plays a role in actin cytoskeleton
organization, regulating actin remodeling though interactions with ADP-ribosylation
factor, Arf6 and guanine nucleotide exchange factor, ARNO

(D’Souza-Schorey &

Chavrier, 2006). Probably acting as a scaffolding protein, aldolase-a plays a role in the
coordination of membrane trafficking, and cytoskeleton dynamics at the cell periphery
(Merkulova et al., 2011). Alternatively, these protein interactions have a demonstrated
role in the regulation of the endosomal/lysosomal protein degradation pathway
(Casanova, 2007) so it is possible that the purpose of this interaction is to shuttle MT-3 to
the lysosome for degradation.
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APPENDIX
METALLOTHIONEIN ISOFORM 3 EXPRESSION IN HUMAN SKIN,
RELATED CANCERS AND HUMAN SKIN DERIVED CELL CULTURES
Abstract
Human skin is a well known target site of inorganic arsenic with effects ranging
from hyperkeratosis to dermal malignancies. The current study characterizes the
expression of a protein known to bind inorganic, As3+, metallothionein 3 (MT-3).
Expression of this protein was assessed immunohistochemically with a specific MT-3
antibody on human formalin-fixed, paraffin-embedded biopsy specimens in normal skin,
squamous cell carcinoma (SCC), basal cell carcinoma (BCC) and melanoma. Assessment
in normal skin using nine normal specimens showed moderate to intense MT-3 staining
in epidermal karatinocytes with staining extending into the basal cells and moderate to
intense staining in melanocytes of nevi. MT-3 immunoexpression was shown to be
moderate to intense in 12 of 13 of SCC, low to moderate in 8 of 10 BCC, and moderate to
intense in 12 melanoma samples. MT-3 expression in cell culture models (normal human
epidermal keratinocytes, normal human melanocytes, and HaCaT cells) showed only
trace expression of MT-3, while exposures to the histone deacytalase inhibitor, MS-275,
partially restored expression levels. These results indicate that the epidermis of human
skin and resulting malignancies express high level of MT-3 and potentially impact on the
known association of arsenic exposure and the development of skin disorders and related
cancers.
Introduction
Inorganic arsenic is a potent human carcinogen, and skin is known to be one of
the most susceptible human organs affected by chronic environmental exposure to this
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metalloid (Bolt, 2012). Chronic arsenic exposure causes a dry skin phenotype
characterized by melanosis, hyperplasia and hyperkeratosis (Komissarova and Rossman,
2010). The most common arsenic-induced skin cancers include Bowen's disease (BD,
SCC in situ), squamous cell carcinoma (SCC), and basal cell carcinoma (BCC) ( Yeh et
al., 1968). There is less evidence for a potential contribution of arsenic exposure to the
development of melanoma. However, there is emerging evidence for such an association,
especially for melanomas that might arise from co-exposure to ultraviolet radiation
( Cooper et al., 2014, Pearce et al., 2012 and Dennis et al., 2010). Cell culture models
have seen frequent use to investigate the mechanisms involved in arsenic-induced
toxicity and cancer development due to the lack of valid animal models. These studies
have led to several theories to explain the carcinogenic effects of arsenic exposure and
include the generation of reactive oxygen species (ROS), oxidative DNA damage,
genomic instability, aneuploidy, gene amplification, inhibition of DNA repair, and
epigenetic dysregulation ( Ren et al., 2011, Straif et al., 2009 and Lee et al., 2012). This
laboratory is interested in how the metallothionein (MT) gene family might participate in
the above processes that are associated with arsenic-induced carcinogenesis. A role for
this family of proteins might be expected since all MT family members can bind and
sequester 6 atoms of As+3 and can also serve as an antioxidant (Vasak and Meloni,
2011, Irvine et al., 2013 and Garla et al., 2013). In humans, there are four MT isoforms,
designated MT-1 through MT-4. The MT-1 and MT-2 isoforms have been the subject of
extensive study over the last 50 years and the subject of numerous reviews (see Vasak
and Meloni, 2011). The MT-1 and MT-2 isoforms are inducible in almost all tissues by a
variety of stress conditions and compounds including glucocorticoids, cytokines, ROS,
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and metal ions. In contrast, the identification of the MT-3 and MT-4 isoforms is relatively
recent (1990s) and both isoforms are largely unresponsive to the above inducers and their
expression believed to be confined to far fewer tissue types. The four MT isoforms share
a high degree of sequence homology and a specific antibody cannot be produced that can
separately identify the MT-1, 2 and 4 isoforms. The MT-3 isoform is unique in that it
possesses 7 additional amino acids that are not present in any other member of the MT
gene family, a 6 amino acid C-terminal sequence and a Thr in the N-terminal region
(Palmiter et al., 1992, Tsuji et al., 1992 and Uchida et al., 1991). An MT-3 specific
antibody can be generated against the C-terminal sequence (Garrett et al., 1999).
Functionally, MT-3 has also been shown to possess several activities not shared by the
other MT isoforms. These include a neuronal cell growth inhibitory activity (Uchida et
al., 1991), the participation in the regulation of EMT in human proximal tubule cells
(Kim et al., 2002 and Kim et al., 2002), and the ability to influence the choice between
apoptotic and necrotic cell death in proximal tubule cells exposed to cadmium (Somji et
al., 2004). This non-duplication of function occurs despite a 63–69% homology in amino
acid sequence among MT-3 and the other human MT isoforms (Sewell et al., 1995).
These unique features of MT-3, along with its ability to bind and sequester As+3,
motivated the present study designed to examine the expression of MT-3 in human skin
and related skin cancers. A related question was to determine if human cell culture
models used to study As+3 effects on skin faithfully recapitulate the in situ expression of
MT-3.
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Materials and Methods
Specimens of human skin
Specimens of normal human skin and associated cancers were obtained from
archival paraffin blocks 10 years post diagnosis and scheduled for disposal as medical
waste. These archival specimens contained no patient identifiers and are in the exempt
category for human research. Tissues within these paraffin blocks were routinely fixed in
10% neutral buffered formalin for 16–18 h. The tissues were transferred to 70% ethanol
and dehydrated in 100% ethanol. Dehydrated tissues were cleared in xylene, infiltrated,
and embedded in paraffin. Tissue sections were cut at 3–5 μm for use in routine
histology and immunohistochemical protocols.
Immunostaining for MT-3 in human skin and associated cancers
Serial sections were cut at 3–5 μm for use in immunohistochemical protocols.
Staining was performed by a Leica Bond–Max automatic immunostainer. Major reagents
for this procedure were contained in the Bond Polymer Refine Detection kit (Leica,
DS9800). Paraffin sections were processed in the machine from deparaffinization to
counterstaining by hematoxyline according to the manufacturer’s recommended
program settings with the following modifications. Briefly, the major steps in the
protocol include deparaffinization, antigen retrieval for 20 min in Bond Epitope Retrieval
Solution 1 (Leica, Catalog No AR9961), peroxide block for 5 min, incubation with rabbit
anti-MT-3 antibody (1:200) for 25 min at room temperature, incubation with Post
Primary for 10 min (source of the anti-rabbit IgG antibody), incubation with Polymer
(source of the anti-rabbit Poly-HRP antibody) for 10 min, visualization with DAB
(diaminobenzidine substrate for color development) for 10 min, counterstaining with
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hematoxylin for 5 min. Slides were rinsed in distilled water, dehydrated in graded
ethanol, cleared in xylene, and coverslipped.The presence and degree of MT-3
immunoreactivity in the specimens was judged by two pathologists. The scale used was 0
to +3 with 0 indicating no staining, +1 staining of mild intensity, +2 staining of moderate
intensity, and +3 staining of strong intensity.
Cell culture
The HaCaT cell line was obtained from Cell Line Services (Eppelheim,
Germany). HaCaT were initially isolated from normal skin of a 62 year old Caucasian
male donor and spontaneously immortalized through p53 mutation; they are
nontumorigenic in vivo ( Boukamp et al., 1988). The cells were maintained in Dulbecco
’s Modified Eagles Medium (DMEM) supplemented with 4.5 g/L glucose, 2 mM Lglutamine, 10% v/v fetal bovine serum (FBS), 0.25 μg/mL fungizone, 100 U/mL
penicillin and 100 μg/mL streptomycin. HaCaT cells were given fresh medium every
72 h and subcultured at a ratio of 1:5. Normal human epidermal keratinocyte (NHEK)
primary cells were obtained from Lonza (Walkersville, MD). NHEK were isolated from a
68 year old Caucasian male donor. The cells were maintained in KBM-Gold (Lonza,
Walkersville, MD) supplemented with KGM-Gold™–BulletKit™ (Lonza, # 00192060).
NHEK were seeded at a density of 3500 cells/cm2 and given fresh media the day after
seeding and then every 48 h until reaching 70–80% confluency. The human epidermal
melanocyte primary cells isolated from a light pigmented donor were obtained from
Gibco (HEMa-LP) (Carlsbad, CA), and are referred to as normal human melanocytes
(NHM). NHM cells were maintained in Medium 254 supplemented with PMA-free
Human Melanocyte Growth Supplement-2 (HMGS-2, Gibco, # S-016–5) 0.25 μg/mL
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fungizone, 100 U/mL penicillin and 100 μg/mL streptomycin. The cells were seeded at a
density of 5000 cells/cm2 and given fresh media the day after seeding and then every 48 h
until reaching 80% confluency.
Treatment of cultured cells with 5-Aza-2-deoxycytidine and histone deacetylase
inhibitor MS-275
HaCaT, NHEK and Primary Melanocytes were seeded at a 1:10 ratio and the next
day they were treated with 1 or 3 μM 5-Aza-2′-deoxycytidine (5-AZC) (Sigma–
Aldrich, St. Louis, MO) or 1, 3 or 10 μM MS-275 (ALEXIS Biochemicals, Lausen,
Switzerland). The cells were allowed to grow to confluency and then harvested for RNA
isolation.
RNA Isolation and RT–PCR analysis
Total RNA was isolated from the cells according to the protocol supplied with
TRI REAGENT (Molecular Research Center, Inc. Cincinnati, OH) as described
previously by this laboratory (Somji et al., 2006). Real time RT–PCR was used to
measure the expression level of MT-3 mRNA utilizing a previously described MT-3
isoform-specific primer (Somji et al., 2006). For analysis, 1 μg was subjected to
complementary DNA (cDNA) synthesis using the iScript cDNA synthesis kit (Bio-Rad
Laboratories, Hercules, CA) in a total volume of 20 μl. Real-time PCR was performed
utilizing the SYBR Green kit (Bio-Rad Laboratories) with 2 μl of cDNA, 0.2 μM
primers in a total volume of 20 μl in an iCycler iQ real-time detection system (Bio-Rad
Laboratories). Amplification was monitored by SYBR Green fluorescence and compared
to that of a standard curve of the MT-3 isoform gene cloned into pcDNA3.1/hygro (+)
and linearized with Fsp I. Cycling parameters consisted of denaturation at 95 °C for
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30 s and annealing at 65 °C for 45 s which gave optimal amplification efficiency of
each standard. The level of MT-3 expression was normalized to that of β-actin assessed
by

the

same

assay

with

the

primer

sequences

being

sense,

CGACAACGGCTCCGGCATGT, and antisense, TGCCGTGCTCGATGGGGTACT,
with the cycling parameters of annealing/extension at 62 °C for 45 s and denaturation at
95 °C for 15 s.
Results
MT-3 expression in human skin and related cancers
The expression of MT-3 was determined in normal human skin, in situ squamous
cell carcinoma, squamous cell carcinoma, basal cell carcinoma, nevus, dysplastic
nevus, in situ melanoma, superficial spreading melanoma, and deeply invasive melanoma
(Table V-1). Nine independent specimens of human skin were evaluated for the
expression of MT-3. All nine specimens displayed immunoreactivity for MT-3 in the
epidermis. For each specimen, the immunoreactivity for MT-3 was uniform throughout
the epidermis and included staining of the basal keratinocytes (Fig V-1A). Six of the
specimens exhibited moderate to strong staining for MT-3 while the other 3 displayed
mild to strong intensity of staining (Table V-1). All squamous cell carcinomas (SCC)
exhibited staining for MT-3 ( Table 1), five strongly ( Fig 1C), six moderately ( Fig V1E), and one mild to moderate, whereas many of the basal cell carcinomas (BCC)
exhibited low staining ( Table 1) with two being totally devoid of MT-3 expression ( Fig
2F), three weakly, and the rest (five samples) were either mild or mild to moderate ( Fig
1D) in MT-3 staining. The staining of MT-3 was determined on 9 specimens of nevus.
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Table V.
Immunostaining of MT-3 in Normal Skin, SCCa, BCCb, Nevi, and Melanoma
Sample #
T06-02611
T06-04747
T06-08104
T06-12296
T06-13822
T06-15093
T06-15738
T06-16832
T06-17515
T06-05920-2
T06-08560-1
T06-10237-1
T06-17492-3
T06-18288
T06-19042-2
T07-02859-3
T07-04441-1
T07-05223-3
T07-07073-2
T08-11243
T09-09643-1
T06-13947-1
T06-00002
T06-03724-2
T06-06686-8
T06-06889
T06-07160-2
T06-08133-2
T06-09327-1
T06-10671-1
T07-00753-2
T07-07197-3
T06-05434
T06-13829
T06-15352
T06-16045
T06-16174
T06-16832
T06-16983
T06-18076
T06-18753
T06-17364
T06-02621
T06-09160
T06-11933
T06-08497
T06-11336
T06-11854
T06-17070
T06-02282
T06-03697
T06-05435
T06-07039
T06-16580

Diagnosis
normal skin
normal skin
normal skin
normal skin
normal skin
normal skin
normal skin
normal skin
normal skin
SCC
SCC
SCC
SCC
SCC
SCC
SCC
SCC
SCC
SCC
SCC
SCC
SCC, in situ
BCC
BCC
BCC
BCC
BCC
BCC
BCC
BCC
BCC
BCC
nevus
nevus
nevus
nevus
nevus
nevus
nevus
nevus
nevus
dysplastic nevus
in situ melanoma
in situ melanoma
in situ melanoma
superficial spreading melanoma
superficial spreading melanoma
superficial spreading melanoma
superficial spreading melanoma
deeply invasive melanoma
deeply invasive melanoma
deeply invasive melanoma
deeply invasive melanoma
deeply invasive melanoma

Intensityc
2-3+
2+
2-3+
2-3+
2-3+
1-2+
2-3+
1-2+
1-2+
3+
2-3+
1+
2+
2-3+
2+
2-3+
2+
2+
1-2+
2+
2-3+
2+
0-1+
1+
0-1+
1-2+
0-1+
NEG
1+
1+
NEG
1-2+
2-3+
2-3+
2-3+
2-3+
2-3+
2-3+
2+
2+
2-3+
2-3+
2-3+
2-3+
2-3+
2-3+
2-3+
2-3+
2-3+
2-3+
2-3+
2-3+
2-3+
2+

Percentaged

90
80
60
80
90
80
70
60
80
30
60
80
80
30
60
80
80
40
0
60
40
0
60
80
80
80
80
80
80
80
80
80
80
80
80
80
80
80
80
80
80
80
80
80
80

Commentse

normal skin 2+
normal skin 2+
normal skin 1-2+
normal skin 2+
no normal skin
no normal skin
normal skin 2+
normal skin 2-3+
normal skin 1+
no normal skin
normal skin 2+
normal skin 2+
no normal skin
normal skin 1-2+
no skin
normal skin 1-2+
normal skin 2+
normal skin 2+
normal skin 1-2+
normal skin 1-2+
normal skin 1-2+
no normal skin
normal skin 1-2+

The sample number indicates the case the tissue source is associated with. MT-3
reactivity was assessed in normal skin, basal cell carcinoma (BCC), squamous cell
carcinoma, melanoma, and nevi (moles)
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Figure V-1. Immunostaining of MT-3 in Skin Pigment Lesions. A: normal skin shows
mild to moderate staining of MT in epidermis (#). In some cases the staining of MT-3 in
epidermis can be moderate to strong (not shown); B: normal kidney as positive control;
C: squamous cell carcinoma (SCC) (T06–5920) with strong staining of MT-3 (3 + ); D:
normal skin from the same slide in “C”, showing moderate positivity of MT-3 (2 + ); E:
SCC (T07–4411) with mild staining of MT-3 (2 + ); F: normal skin from the same slide
as shown in “E”, showing moderate staining of MT-3 (2 + ); G: SCC (T06–10237) with
mild staining of MT-3 (1 + ); H: basal cell carcinoma (BCC) (T06–00002) with focal,
very weak staining of MT-3 (0–1 + ); I: Normal skin from the same slide as shown in
“H”, showing mild to moderate staining of MT-3 (1–2 + ); J: BCC (T06–7889) with
mild-moderate staining of MT-3 (1–2 + ). All images taken at 200X magnification.
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Staining for MT-3 was found for all 9 specimens, exhibited moderate to strong intensity,
and was present in over 80% of the cells comprising the nevus (Table 1, Fig 2A).
Staining of MT-3 was also performed on 1 case of dysplastic nevus and 3 cases of in
situ melanoma. The staining was similar to that found in the nevus with all specimens
displaying moderate to strong staining in over 80% of the cells ( Table 1, Fig 2B).
Staining of MT-3 was also performed on 4 cases of superficial spreading melanoma and 5
cases of deeply invasive melanoma. Again, the staining was similar to that found for in
situ melanoma with moderate to strong staining of MT-3 in over 80% of the melanoma
cells (Table V-1, Fig V-2C, D, E).
MT-3 expression in primary normal human keratinocytes (NHEK) and immortalized
human HaCaT keratinocytes
Proliferating and confluent cultures of NHEK and HaCaT cells were assessed for
their expression of MT-3 mRNA and protein. Real time PCR demonstrated that both
resting and dividing NHEK and HaCaT cells had only background levels of MT-3
mRNA expression (Fig V-3A, B). Both sets of cells were also shown to express only
background levels of MT-3 protein (data not shown). Both the NHEK and HaCaT cells
were treated with MS-275, a histone deacetylase inhibitor, and 5-aza-2-deoxycytidine, a
DNA methylation inhibitor, to determine if MT-3 expression might be silenced by a
mechanism involving histone modification or DNA methylation. The results
demonstrated that treatment with MS-275 was effective in restoring MT-3 mRNA
expression in both the NHEK and HaCaT cells (Fig V-3A,B).
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Figure V-2. Immunostaining of MT-3 in Nevi and Melanoma Cells. A: in this
intradermal nevus, the neval cells, which located in the dermis, show moderate to strong
expression of MT-3 (*). The epidermis at the top of the image is moderately positive for
MT-3 (#); B: in this case of in situ melanoma, two nests of melanoma cells in the
epidermis are moderately to strongly positive for MT-3 (*). The epidermis is moderately
positive for MT-3 (#); C: in this superficial spreading melanoma, some melanoma nests,
located in the superficial dermis, show strong staining of MT-3. The overlying epidermis
is mildly positive for MT-3 (#); D: in this deeply invasive melanoma, the tumor cells are
strongly positive for MT-3 (*). In the top-left corner is a small section of epidermis (#),
which is mildly positive for MT-3 (#); E: another case of deeply invasive melanoma. In
the center of this image is a hair follicle (+) with two keratin pearls (arrows) in it. The
hair follicle shows moderate staining of MT-3. Around the follicle are nests of invasive
melanoma cell (*), which show strong staining of MT-3. F: BCC (T06–8133) with
negative staining of MT-3.
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While MS-275 treatment was effective in both cell lines, MS-275 increased MT-3 mRNA
levels in NHEK cells 10 to 20 fold greater than those of the HaCaT cell line. Treatment
of the NHEK and HaCaT cells with 5-aza-2′-deoxycytidine, resulted in a small, but
statistically insignificant increase in MT-3 mRNA expression for both cell types (Fig V3A, B).
MT-3 expression in normal human melanocytes (NHM)
Normal human melanocytes (from a light pigmented donor) were assessed in
proliferating and confluent cultures for expression of MT-3 mRNA and protein. Both cell
cultures showed only background levels of mRNA as demonstrated with real-time PCR
(Fig V-3C) and only background levels of protein (data not shown).
In order to test for epigenetic regulation, cultures were treated with the histone
deacetylase inhibitor, MS-275 and the DNA methylation inhibitor, 5-aza-20doxycytidine. The results demonstrated that treatment with MS-275 was effective in
restoring MT-3 mRNA expression in the NHM cells (Fig V-3C). Treatment of the
HEMa-LP with 5-Aza-20-deoxycytidine, resulted in only a slight but statistically
significant increase in MT-3 mRNA expression (Fig V-3C).
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C:

Figure V-3. Expression of MT-3 in primary normal human keratinocytes (NHEK),
Immortalized Human Keratinocytes (HaCaT), and normal human melanocytes
(HEMa-LP). NHEK (A) HaCaT (B) and HEMa-LP (C) cells were exposed to 1, 3, or 10
μM of the histone deacetylase inhibitor MS-275 for up to 72 h, or to 1 or 3 μM 5azacytidine for 24 h. The post-confluent control was held at confluency for at least 72 h.
Messenger RNA levels for MT-3 were assessed using real-time PCR and gene specific
primers on RNA isolated from cells in culture. Expression levels are expressed as
transcripts per 1000,000 transcripts of β-actin which was also assessed using real-time
PCR. Significant differences from control groups are designated as **p < 0.005, ***p <
0.0005 as determined by student’s unpaired t-test.
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Discussion
The present study establishes that MT-3 is expressed in human skin. The
immunoreactivity for MT-3 was present in all viable keratinocytes comprising the
epidermis. The finding that MT-3 was present in the epidermal keratinocytes has a
potential impact on the known association of arsenic exposure and the development of
skin disorders and related cancers. All members of the MT gene family (MT-1, -2, -3 and
-4) are known to bind heavy metals, including As+3 (Vasak and Meloni, 2011, Irvine et
al., 2013 and Garla et al., 2013). Previous studies employing a monoclonal antibody
against the E-9 epitope of the MT-1, -2, and -4 isoforms demonstrated that these 3
isoforms are poorly expressed in human skin and with expression restricted to the basal
keratinocytes (Van den Oord and Delay, 1994, Karasawa et al., 1991 and Zamirska et al.,
2012). The high sequence homology of these 3 isoforms prevents the generation of
specific antibodies to the individual isoforms. In contrast, the present study shows that a
large majority of keratinocytes in the epidermis of normal human skin are moderately to
strongly immunoreativity for MT-3. These findings were consistent for 9 independent
samples of human skin. The antibody used for the localization of MT-3 is specific since it
was generated against the unique C-terminal amino acid sequence that is present only in
this MT isoform (Garrett et al., 1999). The fact that human keratinocytes contain
substantial levels of MT-3, and that MT-3 can bind As+3, suggests a possible role for MT3 in the selective accumulation and sequestering of As+3 in skin. One hypothesis to
explain why skin is highly responsive to arsenic exposure and cancer development is that
skin localizes and store As+3 due its high keratin content and the corresponding favorable
interaction with sulfhydryl groups (Kitchen, 2001 and Lindgren et al., 1982). The current
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finding suggests that MT-3 might play an additive, or possibly larger, role in the ability
of skin to sequester and store As+3 in individuals chronically exposed to this metalloid.
Evidence to support the concept that MT expression in a normal target tissue can elicit
chronic effects can be found in the nephropathy associated with chronic exposure to
cadmium. The MT-1 and MT-2 isoforms are predominantly expressed in the proximal
tubules of the human kidney, and this expression is initiated during the early development
of the kidney (Mididoddi et al., 1996). The MT-3 isoform is also expressed in the
proximal tubules and other tubular elements of the human kidney (Garrett et al., 1999).
The cortex of the human kidney has been shown to accumulate cadmium, as a function of
age, in humans without occupational exposure (Satarug et al., 2002 and Satarug et al.,
2010). Accumulation is assumed to occur through cadmium's interaction with MT and
accumulation has been shown to reach a plateau at approximately 50 years of age.
Despite the MT's being looked upon as having a protective role against heavy metal
toxicity in general, and the proximal tubule in particular (Liu et al., 1995, Liu et al.,
1998, Liu et al., 2000 and Masters et al., 1994), the fact remains that the kidney and the
proximal tubule is the cell type critically affected by chronic exposure to cadmium
(Andrews, 2000, Bernard et al., 1976, Bosco et al., 1986 and Gonich et al., 1980). It has
been shown in human population studies that even low exposure to cadmium alters renal
tubule function (Akesson et al., 2005). Thus, there is evidence in the kidney that preexisting expression of MT in the renal tubules both protects the kidney from cadmium
exposure, but this expression might also render the organ susceptible to the chronic
effects of the metal. There is little evidence, either for or against, that would support a
similar role for MT-3 expression in human skin as regards the chronic effects of exposure
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to arsenic. The present study demonstrates that MT-3 is prominently expressed in the
majority of cells comprising the nevus, dysplastic nevus, in situ melanoma, superficial
melanoma, and deeply invasive melanoma. Although the sample set was relatively small,
there was no indication that expression was variable within or between disease
categories. A consequence of this pattern of constant MT-3 expression is that the
melanocytes, in all stages of progression, are able to continue to bind and accumulate
As+3 in an environment where exposure to As+3 is at elevated levels. Unfortunately, there
is very little information in the literature on conditions or mechanisms in vivo that would
influence the release of As+3 from MT-3 inside a cell or tissue. One could speculate that
if ultraviolet radiation influenced the release of As+3 from MT-3, it might impact on
emerging research which suggests a linkage between the development of melanoma and
co-exposure to As+3 and ultraviolet radiation ( Cooper et al., 2014). The expression of
MT-1 and -2 has been examined in patients with melanoma. It was shown that a gain of
expression of MT-1 and -2 is an adverse prognostic and survival factor for patients with
this cancer ( Weinlich et al., 2003 and Weinlich et al., 2006). In contrast to MT-3, MT-1
and -2 is not expressed in the nevus and is gained later during the development of the
cancer. The present study also shows that MT-3 is expressed in the normal human
epidermal keratinocytes that would give rise to these cancers. The examination of these
cancers show that all SCC exhibit robust expression of MT-3, and that the majority of
BCC express MT-3 although a significant proportion express mild levels and some BCC
failed to immunostain for this protein. The results of the present study also show that cell
cultures of NHEK, HaCaT immortalized human keratinocytes, and normal human
melanocytes do not express MT-3 as would be unexpected from their in situ patterns of
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MT-3 expression. This observation shows that these cell lines are lacking a protein that
can both bind and sequester As+3 as well as serving as an antioxidant. The MT-3 protein
has also been shown to have growth inhibitory activity outside the neural system ( Gurel
et al., 2003), be involved in necrotic and apoptotic cell death ( Somji et al.,
2004 and Somji et al., 2006) and in the epithelial to mesenchymal transition ( Kim et al.,
2002 and Bathula et al., 2014). Exactly how this might impact on studies using these cell
lines to elucidate the mechanism/s of As+3 toxicity and carcinogenicity is unknown, but
may need to be considered in the interpretation of past and future studies. The loss of
MT-3 expression in cell cultures derived from tissues where MT-3 is expressed may be a
result of the cell culture environment. This is suggested by studies on MT-3 expression in
bladder cancer and breast cancer cell lines. This laboratory has shown that the epithelial
cells of the human bladder and breast do not express MT-3, but that the majority of
patient specimens of breast and bladder cancers do express MT-3 ( Sens et al., 2000, Sens
et al., 2001, Zhou et al., 2006 and Somji et al., 2010). In studies examining MT-3
expression in As+3 and Cd+2transformed bladder cancer cell lines and in MCF-7, T-47D,
Hs 578 t, MDA-MB-231 breast cancer cell lines it was demonstrated that none of the cell
lines expressed MT-3 ( Zhou et al., 2006). However, when these cell lines were
transplanted into immune compromised mice, all the resulting tumors showed prominent
expression of MT-3. It has also been shown that the expression of MT-3 mRNA could be
induced under cell culture conditions in the MT-3 non-expressing cell lines following
treatment with MS-273, a histone deacetylase inhibitor ( Somji et al., 2010 and Somji et
al., 2011). These results suggest that MT-3 is silenced under cell culture conditions by a
mechanism involving histone acetylation. Previous to the submission of this manuscript,
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no studies of MT-3 expression in human skin or derived cancers existed in the literature;
however, recently a study was published during the review process that documents the
expression of MT-3 in human skin, both in normal as well as BCC and SCC (Pula et al.,
2014). The findings of this study are in overall agreement with the above findings with
the exception that they have found higher levels of MT-3 in SSC whereas the current
study did not. Nevus, melanoma and cultured cell models were not assessed in this study.
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